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Infective endocarditis (IE) is a life-threatening disease, associated with an 
accumulation of bacteria and host components as vegetations on the endocardial 
surface of the heart. Streptococcus gordonii, an initial coloniser of the oral cavity, is 
frequently associated with IE pathogenesis. Previous studies have indicated the 
capacity for S. gordonii to interact with platelets within the blood to promote 
vegetation formation, mediated by surface adhesins PadA and Hsa. However, few 
studies have explored the ability of this bacterium to survive upon entry into the 
blood stream or to interact with cardiac tissue. The aim of this project was therefore 
to better characterise the interactions of S. gordonii with blood components and 
human coronary artery endothelial cells (HCAEC), with a particular focus on the 
roles of PadA and Hsa. Proteomic studies were used to identify interactions of 
PadA/Hsa with HCAEC and plasma proteins, combined with in vitro assays to 
investigate survival of wild-type S. gordonii or PadA/Hsa knockout mutants in human 
serum and their interactions with vitronectin and neutrophils. Potential strategies 
were identified that may enable S. gordonii to evade complement-mediated killing 
and other immune defences, to which both Hsa and PadA contributed. Further 
insight into the capacity for S. gordonii to target damaged cardiac tissue and 
exacerbate vegetation formation was also provided. Taken together, this information 
advances understanding of the mechanisms that may enable S. gordonii to survive 
within blood and promote IE which, in turn, could assist the development of novel 
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COVID-19 Impact Statement 
 
Unfortunately, the UK went into national lockdown at the end of March 2020, 
meaning that all postgraduate laboratory work had to be discontinued within the 
university. A visit to the Waller group to complete TraDIS studies was planned for 
April 2020, but this had to be cancelled due to the circumstances and the studies 
described in this project were therefore halted. In addition, further work was 
planned for this project throughout the summer months, including the use of flow-
cytometry and further experiments using vitronectin which unfortunately could not 
be carried out due to UK lockdown. Throughout this project, there were several 
difficulties faced, such as the breakdown of laboratory freezer meaning that 
samples were lost, and incorrectly prepared samples which were to be used for 
experiments. Some of the S. gordonii surface protein experiments would have 
included both single and double knock-out strains, however, these overnight 
cultures were incorrectly prepared or were prepared using thawed reagents, 
rendering these cultures unsuitable for experimental work right at the last minute, 
before lockdown began. 
In order to complete the project to a high standard, proteomic analysis was 
included, where previous generated data was analysed further to identify 
interactions that were not observed in previous studies. Because TraDIS studies 
and further work using blood could not continue, proteomics studies could be 
completed from home and over online calls to the proteomics facility. Proteomics 
studies would then become a large part of this thesis, replacing experiments that 





















































1.1 The oral environment 
It is estimated that around 700 different prokaryotic species are able to inhabit the 
oral cavity, with those identified to date recorded in the Human Oral Microbiome 
Database (HOMD). Up to 200 of these species may be found in any one individual 
at a given time (Cunha et al., 2010). Around 13% of these species are unnamed, 
and it has been challenging to fully characterise every species due to, for example, 
cultivation difficulties. However, some of the most abundant species found within 
the oral cavity are those belonging to the Streptococcus genus, with around 26 
species found able to inhabit the oral cavity to date (Cunha et al., 2010). 
The oral cavity contains a range of different microenvironments and habitats for 
these prokaryotes; for example, hard tissue surfaces such as the teeth and softer 
tissues such as the gingival sulcus, tonsils, tongue and gingivae (Cunha et al., 
2010). These environments can be hostile and difficult to survive in, due to the 
constant movement of food and the tongue, oral hygiene procedures carried out by 
the host such as brushing or flossing, and the release of acids into the environment 
by some commensal species within the oral cavity in a bid to out-compete others 
(Cunha et al., 2010). To overcome these conditions, many bacterial species within 
the oral cavity form a biofilm to allow them to survive. 
A biofilm is a collection of microorganisms surrounded by extracellular polymeric 
substances (EPS), which can provide the microorganisms with protection, nutrients 
and oxygen availability (Cunha et al., 2010). Dental plaque is an example of a 
biofilm, composed primarily of oral microorganisms, components of food such as 
sugars, EPS and salivary components, which in turn are bound to the salivary 
pellicle on teeth (Huang et al., 2011). This salivary pellicle is a thin, acellular film 




cavity. Several oral bacteria, such as Streptococcus gordonii and Streptococcus 
mutans, are able to adhere to and subsequently colonise the pellicle found on teeth, 
which can initiate formation of the plaque biofilm (Rath et al., 2017). These bacteria 
are often referred to as primary colonisers.  
As shown in Figure 1.1, bacteria first entering the oral cavity will be present in a 
planktonic state, which allows them to freely move within saliva. Primary colonisers 
will interact with and bind to the salivary pellicle. These bacterial cells can then co-
adhere with other cells, allowing further microorganisms to be recruited to the 
growing biofilm by attaching to those cells already bound. Ultimately, all of these 
species exist as a community in a ‘sessile’ or static state, which is embedded within 
a matrix of extracellular polymeric substances (EPS) produced by the 
microorganisms. This represents the mature biofilm stage, and microbes may later 
undergo dispersion and release from the biofilm (Huang et al., 2011). 
Figure 1.1 – Simplified schematic to illustrate dental plaque biofilm formation  
A – Formation of the salivary pellicle on the tooth surface. B – Initial adhesion of 
primary colonisers, such as oral streptococci, to the salivary pellicle. C – Maturation 
of the biofilm as more species join via co-adhesion and produce EPS, entering a 






1.2 Oral health vs. general health  
Oral disease is a major area of research focus from both an oral biology and public 
health perspective. Oral diseases such as periodontitis are some of the most 
prevalent, chronic health conditions seen around the world (Griffin et al., 2012) and, 
if left untreated, can lead to prolonged pain and adverse health outcomes 
(Abranches et al., 2018). The health of the oral cavity can significantly impact an 
individual’s ability to eat and make food choices, with studies showing that tooth loss 
amongst older people can contribute to weight loss, obesity or vitamin depletion. An 
individual with tooth loss due to oral disease will likely choose easier-to-chew foods, 
due to their lack of complete dentition or pain experienced during eating (Savoca et 
al., 2010). Additionally, tooth loss can have an emotional impact, and be detrimental 
to an individual’s self-esteem and well-being. Studies have demonstrated that 
individuals with tooth loss are more likely to avoid social situations or eating in public, 
for fear of embarrassment or wishing to hide their appearance (Gerritsen et al., 
2010). Oral disease therefore contributes to several problems an individual may 
face, not only including pain and difficulty eating, but negatively impacting an 
individual’s self-confidence.  
Alongside local disease manifestations, it has been widely recognised for several 
decades that there is a relationship between oral health and general health. It has 
been suggested that the oral cavity is a ‘window to general health’, at the intersection 
of medicine and dentistry, as it is an area of the body that interacts with the external 
environment. It is also the entry point for both the respiratory and gastrointestinal 
tracts within the body, a feature that can be both harmful and beneficial for the health 




and systemic disease date back to when Hippocrates claimed to have cured a 
patient’s rheumatoid arthritis by removing one of their infected teeth (Kumar, 2017). 
In the 17th century, a Dutch scientist, Antonie van Leeuwenhoek, obtained a sample 
of his own dental plaque by scraping his teeth to test his new microscope. He 
famously described what he saw on the glass slide as ‘little animalcules’, introducing 
the idea that the oral cavity contained small, living microorganisms that were likely 
causing disease within the oral cavity and throughout the body (Chapple, 2009). 
This discovery, alongside Hippocrates’ claims, eventually contributed to the 
introduction of the ‘focal infection theory’ in the 19th and 20th centuries, which 
suggested that oral infections may be responsible for other diseases found around 
the body. This led to medics at the time hypothesising that infections that are 
localised at one site may eventually spread to other parts of the body (Chapple, 
2009).  
Based on the focal infection theory, in more recent centuries the removal of 
diseased teeth has been commonplace in dental practice to minimise risk of 
systemic disease, especially as a strategy to avoid cardiac disease or rheumatoid 
arthritis (Kumar, 2017). Today, such procedures are now driven by an even greater 
understanding of the relationship between oral disease and general health. For 
example, prior to a patient undergoing heart surgery, an oral clearance examination 
is necessary to assess whether poor oral health contributed to the heart issue or 
could contribute to further infection post-surgery. In addition, any infected teeth are 
often removed prior to surgery, to ensure they do not contribute to further infection 






1.3 Oral streptococci in health and disease  
Streptococci are Gram-positive, non-motile, non-spore forming facultative 
anaerobes that commonly grow in pairs or chains. Streptococci are characteristically 
round or ovoid in shape and approximately 1 µm in diameter (Yumoto et al., 2019). 
They are found in association with mucosal tissues throughout the human body, 
including the upper respiratory tract, and account for approximately 20-30% of all 
bacterial species within the mouth, although this can vary amongst individuals 
(Cahill et al., 2017). Streptococci were initially classified based on their ability to 
undergo haemolysis on blood agar, with β-haemolysis meaning complete 
haemolysis, α-haemolysis meaning partial haemolysis and γ-haemolysis meaning 
non-haemolytic. Species that undergo α-haemolysis on blood agar are referred to 
as ‘viridans’ streptococci, taken from the Latin word viridus, which means green 
(Abranches et al., 2018). These bacteria produce hydrogen peroxide, which oxidises 
haemoglobin within blood to green methaemoglobin, and a number of oral 
streptococci fall within this group (Facklam, 2002). Viridans streptococci are 
associated with a number of systemic infections and are commonly isolated from 
patients with bacterial endocarditis or from neutropenic patients suffering from 
cancer. Viridans streptococci can be difficult to eradicate using antibiotics, and 
penicillin resistance was shown to be as high as 48% in strains obtained from the 
USA (Facklam, 2002). 
A modern approach for classifying streptococci is based on 16S rRNA sequencing, 
and this has resulted in the oral streptococci being divided into six major 
phylogenetic groups: anginosus, mitis, sanguinis, salivarius, downei and mutans 
groups (Richards et al., 2014). The mitis and sanguinis groups are commonly 




groups, such as S. gordonii, are frequently isolated from patients with infective 
endocarditis (IE) and in rare cases, with bacterial meningitis (Cahill et al., 2017; 
Kutlu et al., 2008). 
 
1.3.1 Role in oral health  
Oral streptococci, such as members of the mitis, sanguinis and mutans groups, have 
been traditionally considered as ‘commensals’ within the oral cavity, but with 
improved understanding of the delicate and dynamic interplay between members of 
the oral microbiota, this description is now considered too restrictive. Many oral 
streptococci can act as probionts, which can be beneficial for the health of the host. 
One example is S. gordonii, which can promote oral health by neutralising acids 
produced by S. mutans (Krantz et al., 2017). Most oral streptococci also produce 
hydrogen peroxide (H2O2), which can inhibit S. mutans and Porphyromonas 
gingivalis. This is advantageous to the host, as S. mutans is strongly associated 
with dental caries, while P. gingivalis is frequently isolated from sites of aggressive 
periodontitis (Abranches et al., 2018). Therefore, the presence of oral streptococci 
can act to dampen the effects of pathogenic species, thus preventing irritation and 
inflammation by the host immune system. In contrast, some oral streptococcal 
species may also serve as ‘accessory pathogens’ (Lamont et al., 2018), based on 
their capacity to enhance disease progression when in association with other 
pathogenic microbes. For example, using a mouse model of periodontal disease, 
alveolar bone loss was enhanced for P. gingivalis in the presence of S. gordonii 
compared to P. gingivalis alone. Therefore, in recognition of their association with 
both oral health and disease, species such as S. gordonii have also been 





1.3.2 Role in systemic disease  
Upon entering the bloodstream, some oral streptococci have been shown to 
contribute to or cause a number of systemic infections (Yumoto et al., 2019). One 
such example is septic arthritis. This is an infection around artificial joints that can 
be exacerbated or caused by oral streptococci and usually occurs when a mixed 
infection of skin commensal species, such as Staphylococcus aureus, occurs 
alongside oral bacteria that have entered the blood. Surgical cultures have been 
obtained from an infected artificial joint replacement and found to contain oral S. 
gordonii (Klein et al., 2015). 
Disseminated intravascular coagulation (DIC) is another bloodstream-related 
condition that has been linked with oral streptococci. DIC is characterised by the 
formation of blood clots throughout the circulatory system, which may result in organ 
failure or death. This can often be triggered by bacterial or fungal infections within 
the blood and group A Streptococcus (GAS) has frequently been associated with 
DIC, in particular during pregnancy (Bryant, 2003). It has been suggested that oral 
streptococci, such as S. gordonii, which are capable of inducing platelet activation 
and subsequent thrombus formation, may play a role in DIC due to the enhanced 
clotting of platelets within the bloodstream (Nobbs et al., 2009). 
Aspiration of oral bacteria into the lungs can cause systemic disease in some 
patients (Cahill et al., 2017). Pneumonia can result from infection by oral 
streptococci, especially amongst patients who suffer from breathing or swallowing 




patient bronchioalveolar lavage fluid identified S. mitis and S. oralis as present, in 
addition to S. pneumoniae (Akata et al., 2016). 
Oral streptococci are also associated with IE, which is discussed in further depth in 
section 1.5. 
 
1.4 Role of streptococcal surface proteins in colonisation and 
pathogenesis  
In general, to be able to colonise the human host or cause infection, bacteria must 
first be able to adhere to host tissues, and this is often facilitated by surface proteins, 
known as adhesins (Chapple, 2009). Oral streptococci express a variety of adhesins 
which, in turn, confer the ability to bind a range of substrata at both oral and extraoral 
sites. For example, oral streptococci can attach to components of the extracellular 
matrix (ECM), such as fibronectin (Back et al., 2017), and components of blood, 
such as platelets and neutrophils (Haworth et al., 2017a; Urano-Tashiro et al., 
2008).  The adhesins found on oral streptococci can be grouped based on their 
structure, but the majority are anchored to the cell wall by transpeptidase sortase A 
via a C-terminal LPxTG motif (Nobbs et al., 2009). Table 1.1 summarises some of 
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1.4.1 AgI/II polypeptides  
The antigen I/II (AgI/II) family polypeptides are found in most species of oral 
streptococci, and this was one of the first adhesin families to be discovered in Gram-
positive bacteria. These polypeptides play a key role in biofilm formation, platelet 
aggregation and tissue invasion, particularly during the onset of periodontal and 
cardiovascular disease (Brady et al., 2010). Within the oral cavity, AgI/II proteins are 
essential for species such as S. mutans and S. gordonii to attach to the salivary 
pellicle, thus preventing their removal from the oral cavity via the flushing action of 
saliva (Jakubovics et al., 2005; Petersen et al., 2002). 
AgI/II family polypeptides have a defined domain structure, including blocks of 
alanine-rich repeats and proline-rich repeats that flank a central variable region 
(Figure 1.2). S. gordonii expresses two AgI/II family polypeptides, designated SspA 
and SspB, which contribute both to coaggregation with other bacteria and 
adherence to multiple substrata such as salivary glycoprotein-340 and epithelial 
cells (Brady et al., 2010; Nobbs et al., 2009). 
 
Figure 1.2 – Structural features of an antigen I/II family polypeptide. Schematic 
indicates a leader peptide (LP), alanine-rich repeats (A), a variable region (V), 
proline-rich repeats (P), a C-terminal region (C), and cell-wall anchorage region 




1.4.2 SRR family  
The serine-rich repeat (SRR) family of polypeptides are glycosylated and contain 
blocks of serine-rich amino acid residues. The number of amino acid residues within 
each SRR protein is highly variable, thus they all differ in size (Lizcano et al., 2012). 
A key SRR protein found on the surface of S. gordonii DL1 is haemagglutinin 
salivary antigen (Hsa), which binds to sialylated carbohydrate regions found on 
multiple targets such as salivary glycoprotein-340 (gp-340) (Takamatsu et al., 2005). 
In fact, studies have shown that adherence of S. gordonii DL1 to surface-bound 
gp340 is dependent upon the expression of Hsa (Loimaranta et al., 2005). In 
addition to glycoproteins, Hsa plays an important role in the binding of bacterial cells 
to platelets via platelet membrane glycoprotein Ibα, especially during shear-
enhanced adhesion. During this mechanism, the shear-flow of blood over 
immobilised bacterial cells enhances the adherence between bacteria and platelets. 
As the blood flow increases, platelet rolling slows to allow for firm adhesion to the 
bacterial cell surface (Yakovenko et al., 2018). 
Hsa contains an N-terminal signal peptide, a basic amino acid residue region (BR), 
two serine-rich regions (SRR1/2) and a C-terminal cell-wall anchoring domain 
(Figure 1.3). The BR has been shown to contribute to the adhesion of Hsa and may 
be a determinant in the functional differences between homologous SRR proteins 





Figure 1.3 – Structural features of the Hsa protein found in S. gordonii DL1 
(Challis). Schematic indicates signal peptide (SP), serine-rich repeat regions 
(SRR1/2), basic amino acid residue region (BR) and cell wall anchoring domain 
(CWAD). Reproduced from Nobbs et al. (2009). 
 
1.4.3 Pili/fimbriae  
Several oral streptococci possess filamentous structures known as fibrils or pili 
(Nobbs et al., 2009). Fibrils are flexible rods approximately 40-400 nm in length, 
whereas pili are 0.3-1 nm. The CshA protein of S. gordonii was identified as the 
main structural component of one of its fibrils and mediates coaggregation with other 
oral bacteria and attachment to fibronectin (McNab et al., 1996). The binding of 
bacteria to fibronectin promotes bacterial colonisation at multiple sites throughout 
the host, such as oral epithelia or cardiac tissue in the case of S. gordonii. 
Adherence of S. gordonii to cardiac endothelium via fibronectin bridging is one 
potential mechanism that may promote the development of IE (Back et al., 2017). 
CshA contains a 3-domain non-repeat region and basic amino acid repeat region 
(Figure 1.4) (Back et al., 2017). Similar fibrils have been found on the surfaces of S. 




Pili are not as common on the surface of oral streptococci but have been reported 
for S. sanguinis (Zhu et al., 2018). Unlike fibrils, pili are formed by the covalent 
attachment of multiple protein subunits. In S. sanguinis, pili comprise PilA, PilB and 
PilC proteins, which can facilitate attachment to fibronectin and other components 
of the ECM (Okahashi et al., 2010).  
 
Figure 1.4 - Structural features of the CshA protein found in S. gordonii DL1 
(Challis). Schematic indicates leader peptide, a 3-domain non-repeat region (NRR), 
an amino acid repeat region (RR) and LPxTG C-terminal anchor motif. Reproduced 
from Back et al. (2017). 
 
1.4.4 PadA  
Platelet adherence protein A (PadA) is another important surface protein found in 
S. gordonii. PadA facilitates the interactions of S. gordonii with platelets by targeting 
platelet receptor GPIIbIIIa, which is considered critical to the capacity for S. gordonii 
to promote IE (Petersen et al., 2010). Previous studies have shown that the PadA 
N-terminal region mediates interactions with platelets (Keane et al., 2010), but more 
recently this region was also found to bind vitronectin, fibronectin and salivary 




colonisation of the oral cavity by contributing to the ability of S. gordonii to form 
biofilms on oral surfaces, such as the teeth and epithelia.  
PadA contains an N-terminal F2 region, comprising a von Willebrand Factor-like 
domain, NGR, RGT and AGD motifs, followed by an extensive repeat region of 
amino acid residues (Figure 1.5) (Haworth et al., 2017b). 
 
Figure 1.5 – Structural features of the PadA protein found in S. gordonii DL1 
(Challis). Schematic indicates N-terminal region, F2 region comprising a von 
Willebrand factor-like domain (vWF-LD) and NGR, RGT and AGD motifs, repeat 
region of amino acid residues and C-terminal LPKTG cell-wall anchor motif. 
Reproduced from Haworth et al. (2017) 
 
1.4.5 Cell-surface nuclease  
Oral S. sanguinis expresses a surface-bound nuclease, known as streptococcal-
wall anchored nuclease (SWAN). This nuclease is capable of degrading DNA and 
has been shown to play a role in S. sanguinis evasion of neutrophil extracellular 




nuclease is homologous to streptococcal nuclease domain A (SndA) found on S. 
gordonii, which also exhibits DNase activity (unpublished data). 
 
1.5 Infective endocarditis  
One systemic disease with which oral streptococci have been particularly 
associated is IE. IE is an umbrella term for the infection of a native or prosthetic 
heart valve or endocardial surface by circulating bacteria (Cahill et al., 2017). IE can 
also include bacterial infection of an indwelling cardiac device, such as a pacemaker 
(Holland et al., 2016). Typically, clots of bacteria, platelets and immune cells will 
form on the cardiac tissue, commonly known as septic or infective thrombi or 
vegetations. This can lead to a septic pulmonary embolism, which can be life 
threatening (Holland et al., 2016). 
Diagnosing IE is difficult and time-consuming, which can allow the disease to 
progress and lead to irreparable valvular damage, which often requires invasive 
surgery. The optimal therapeutic strategy varies from patient to patient, but antibiotic 
or anticoagulant therapy is often not successful due to antibiotic resistance or 
difficulty with the agent penetrating vegetations (Gould et al., 2012; Thuny et al., 
2012). 
 
1.5.1 Epidemiology  
Over the past five decades, the incidence of IE has been relatively rare, and the 
prevalence of the disease shows significant variation across continents (Li et al., 




rheumatic heart disease has remained the key risk factor for IE, particularly amongst 
young adults and men (Cahill et al., 2017). Additional risk factors worldwide include 
both intravenous drug use and diabetes, as these can facilitate direct access to the 
blood by skin commensals via needles or open wounds and ulcers (Thuny et al., 
2012). In higher-income countries such as the UK, a number of risk factors for IE 
are associated with advancements in medical treatments (Cahill et al., 2017). 
Invasive procedures such as valve replacement and indwelling cardiac devices 
amongst a variety of age-groups are major contributors to IE development. This is 
due to the level of open-heart surgery required, which increases the likelihood of 
infection both during and after surgery (Baddour & Prendergast, 2018). 
 
1.5.2 Pathophysiology  
In health, the valvular endothelium and cardiovascular system should be a sterile 
environment, resistant to microbial colonisation (Mathew & Bhimji, 2018). However, 
microorganisms may enter the bloodstream by a variety of routes, leading to 
bacteraemia. Common routes of infection are by contamination of oral or skin 
wounds, or infection of indwelling medical devices such as catheters or intravenous 
lines (Baddour et al., 2015). In recent years, oral disease or trauma caused by, for 
example, tooth extraction or periodontal surgery, have been recognised as 
contributing factors to IE development (Cahill et al., 2017). Daily events such as 
mastication (chewing) also have potential to facilitate the transient entry of bacteria 
into the blood (de Souza et al., 2016). 
Once bacteria are in the blood, they utilise a variety of virulence factors to enable 




include surface proteins that can facilitate adhesion to ECM components such as 
fibronectin, which can allow bacterial cells to attach and establish an initial infection 
site (Haworth et al., 2017a). Usually in IE patients, alongside bacteraemia, 
individuals will have a damaged or roughened endocardial surface. This can be 
caused, for example, by high blood pressure or suturing. This roughened surface 
provides an attachment point for viable bacteria within the bloodstream, from which 
the bacteria can promote thrombosis (clot formation) and the development of 
infective vegetations (Holland et al., 2016). 
 
1.5.3 Microbiology  
Around 80-90% of IE cases are caused by Staphylococcus, Streptococcus and 
Enterococcus bacteria, with Staphylococcus aureus being the most frequently 
isolated microorganism in high-income countries (Cahill et al., 2017). As a skin 
commensal, S. aureus often colonises indwelling lines, allowing easy access into 
the bloodstream. Oral viridans group streptococci are responsible for around 40-
60% of endocarditis cases occurring on natural heart valves (Rath et al., 2017). 
 
1.5.4 Mechanisms of streptococcal-induced IE  
To promote IE, causative agents must be able to attach to the site of cardiac 
damage. For S. gordonii, one potential mechanism that has been proposed is via 
binding to exposed components of the ECM (Nobbs et al., 2009). S. gordonii can 
bind to fibronectin using its multi-fibrillar surface protein CshA, via an N-terminal 




CshA to attach strongly to fibronectin, even under shear conditions (Back et al., 
2017). 
A key aspect of the pathogenesis of IE is then the interactions of bacteria with 
platelets to drive the unwanted thrombosis on heart valves. Across the oral 
streptococci, such interactions have been most extensively characterised for S. 
gordonii. PadA and Hsa adhesins expressed on the surface of S. gordonii have been 
shown to bind platelets in a synergistic mechanism (Haworth et al., 2017b). Hsa 
mediates the initial interaction with platelets via receptor GPIbα, which aids capture 
of platelets from the bloodstream and platelet rolling over the area of endothelial 
damage (Haworth et al., 2017b). As the platelets slow, PadA then interacts with the 
platelet receptor GPIIbIIIa, which promotes firm platelet adhesion and triggers 
platelet activation (Petersen et al., 2010). This, in turn, leads to further platelet 
recruitment due to platelet aggregation, mediated by AgI/II proteins and Hsa 
(Jakubovics et al., 2005). This accumulation of platelets and bacteria can be further 
targeted by cells of the immune system, such as neutrophils and macrophages. 
Ultimately, this process leads to the accumulation of host cells and bacteria, known 
as the septic thrombus, attached to the cardiac endothelium (Figure 1.6) (Cahill et 







Figure 1.6 – Interactions of S. gordonii with platelets in IE. The initial interaction 
of S. gordonii Hsa with platelet receptor GPIbα facilitates the slowing down of 
platelets and platelet rolling (A). This, in turn, facilitates the interaction of S. gordonii 
PadA with platelet receptor GPIIbIIIa, leading to firm adhesion and platelet activation 
(B). Ultimately, additional recruitment of platelets via aggregation and interactions 
with immune cells leads to formation of the infective vegetation on the cardiac 
endothelium (C). 
 
1.6 Bacteraemia  
In health, blood is a sterile environment; however, it can become compromised by 
bacteria entering through a variety of mechanisms e.g. wound, surgery, 
toothbrushing. Once bacteria are present within blood, this is known as 
‘bacteraemia’, and can cause a variety of problems and result in bacterial 
accumulation at vital organs (Baddour et al., 2015). Bacteraemia is a key factor in 






1.6.1 Components of blood  
Blood is a mixture of proteins and cellular elements, which in general include 
platelets, erythrocytes, plasma and leukocytes (Basu & Kulkarni, 2014). Platelets 
regulate haemostasis and thrombosis following tissue injury (Holinstat, 2017), whilst 
erythrocytes facilitate the transport of gases around the body (Basu & Kulkarni, 
2014). Leukocytes, commonly known as white blood cells (WBCs), circulate within 
the blood to help the body fight infection. They are classed into granulocytes, 
monocytes and lymphocytes, with granulocytes being an umbrella term for 
neutrophils, eosinophils and basophils (Rosales et al., 2017). The liquid component 
in which all of these cells are suspended is plasma. Plasma is approximately 90% 
water, but also contains coagulants such as fibrinogen, plasma proteins, electrolytes 
such as potassium and sodium, and immunoglobulins to fight infection. The term 
serum refers to plasma lacking fibrinogen (Mathew & Bhimji, 2018). 
 
1.6.2 Immune defences in blood  
The innate immune system is the first line of defence within the host to protect 
against invading microorganisms. This response is immediate and is not dependent 
upon previous exposure to microorganisms, in contrast to the acquired immune 
response. The innate immune system is comprised of many components that act in 
unison to protect the host against microorganisms, including physical barriers (such 
as mucous membranes), antimicrobial peptides (AMPs), interstitial fluid, 
antimicrobial proteins and WBCs (Fallis, 2013; Kobayashi et al., 2018). 
The innate immune response works to rapidly recognise microorganisms and 




macrophages and mast cells, to the affected area. These immune cells then function 
to recognise pathogen-associated molecular patterns (PAMPs) expressed by the 
microbes that have entered the host. Toll-like receptors (TLRs) and nucleotide 
oligomerization domain (NOD) receptors recognise these PAMPs, amplifying 
inflammation and activating the adaptive immune response via antigen presentation 
(Carrillo et al., 2017). WBCs are the key immune cells found in blood that act to 
rapidly target and remove microbes, and macrophages and neutrophils are some of 
the first cells to arrive at a site of infection (Uriarte et al., 2016). 
 
1.6.2.1 Neutrophils  
Neutrophils mature in the bone marrow and are released into peripheral vasculature 
as a first line of defence during the innate immune response. Neutrophils can 
recognise components of pathogens or respond to inflammatory signals such as 
cytokines (Rosales et al., 2017). This causes neutrophils to migrate to the site of 
infection, utilising rolling adhesion to attach to endothelial cells (Rosales et al., 
2017).  
Neutrophils employ a variety of mechanisms to facilitate bacterial killing, such as the 
use of their granular components and phagocytosis (Figure 1.7). Neutrophils attach 
to bacteria using TLRs and NOD receptors, after recognition of PAMPs and 
opsonins on the bacterial cell surface (Kobayashi et al., 2018). Once bacteria have 
been recognised and bound, neutrophils begin the process of engulfing the bacterial 
cell, forming a phagosome. Within the phagosome, different neutrophil granule 
types can assemble and eventually liberate their contents, which are required for 




reactive oxygen species (ROS) and nitric oxide species (NOS) (van Kesse et al., 
2014) 
 
Figure 1.7 - The antibacterial actions of neutrophils once activated. Neutrophils 
are capable of phagocytosing bacteria or undergoing degranulation and the 
subsequent release of antimicrobial compounds such as ROS and NOS. 
Phagocytosis often requires the presence of ROS species within the phagosome to 
aid destruction of the bacteria. Neutrophils also release extracellular traps (NETs) 
during degranulation to trap and kill bacteria. Reproduced from Perobelli et al. 
(2015). 
 
Another antibacterial mechanism widely employed by neutrophils is the production 
of NETs. NET production is often a cell death process, known as lytic NETosis, 
which involves the loss and expulsion of neutrophil intracellular membranes followed 




intracellular components around the bacteria (Teng et al., 2017). ROS production is 
required for NETosis to occur, as activity of the NADPH oxidase enzyme complex 
(PHOX) is essential for autophagy of the neutrophil (Castanheira & Kubes, 2019). It 
is also the level of ROS present that determines whether the NETosis reaction will 
be lytic (ending in cell death) or non-lytic (Brinkmann & Zychlinsky, 2012; Stoiber et 
al., 2015). 
 
1.6.2.2 Complement  
A large component of the innate immune system is the complement system, which 
can be found in the blood plasma (Mathew & Bhimji, 2018). This system is 
comprised of approximately 40 different, inactive plasma proteins, which can be 
activated via various mechanisms, such as the presence of pathogen-bound 
antibodies (Lambris et al., 2008). There are three different pathways by which the 
complement system can be activated: the alternative pathway, the mannose-binding 
lectin pathway and the classical pathway (Figure 1.8) (Ekdahl et al., 2018). The 
overall outcome of the complement system is to generate a membrane attack 
complex (MAC), recruit phagocytes and opsonise invaded microorganisms. The 
MAC is a hydrophilic pore comprised of complement proteins C5-9 that spans the 












Figure 1.8 – Simplified schematic to illustrate the three complement pathways. 
There are three different ways in which the complement system can be activated: 
the classical pathway is activated primarily by antigen-antibody complexes. The C1 
complex binds to the antibody, which is bound to the antigen, generating the C3 
convertase enzyme complex. The mannose-binding lectin pathway is activated by 
mannose-binding lectins or ficolin (carbohydrate-binding proteins) to mannose 
groups found on the bacterial cell surface. This ultimately promotes C3 convertase 
activity within the classical pathway. The alternative pathway differs and is initiated 
by microbial surface determinants, whereby hydrolysed C3 and factor B lead to 
subsequent formation of the C3 convertase C3bBb. This allows further generation 
of the C5 convertase enzyme, which initiates formation of the C5b-9 terminal 
complex. This complex is known as the membrane attack complex (MAC) and is the 
ultimate goal of the complement system. This complex allows pores to form on the 
bacterial surface, which can lead to bacterial cell swelling, leakage and death. 




1.6.3 Bacterial immune evasion strategies  
There is a plethora of mechanisms that can be employed by bacteria to evade host 
immune defences, and these can differ between ecological niches within the host 
(Figure 1.9). Mechanisms commonly utilised by bacteria at sites throughout the body 
include the expression of surface proteins that are recognised by immune defences 
as ‘self’ antigens, known as host mimicry (Foster, 2005) and cleavage of host 
proteins (Lambris et al., 2008). For bacteria within the blood, many are able to 
promote their survival via evasion of both the complement system and neutrophil-
mediated killing (Castanheira & Kubes, 2019). 
Figure 1.9 – Simplified schematic to illustrate bacterial immune evasion 
strategies. Some bacteria express molecules on their surface that are alike to those 
found on host tissues (A), whilst others may bind and present host proteins such as 
complement C3b (B); these two mechanisms are described as ‘host mimicry’. 
Bacteria can secrete toxins that damage host immune components (C). Certain 
bacteria produce a capsule that provides protection as a thick, outer layer on the 
bacterial cell surface, which is difficult to penetrate and may camouflage the 
bacterial cell from the host immune system (D). Based on Foster (2005), Lambris et 




1.6.3.1 Evasion of the complement system  
Bacteria utilise a variety of mechanisms to evade the complement system, such as 
producing surface proteins or inhibitors that target complement proteins, mimicry of 
the complement system, or producing proteases to degrade complement proteins 
(Lambris et al., 2008). It is usually the complement components that function as part 
of a feedback loop or as a regulator that are targeted by bacteria and exploited for 
their advantage (Schmidt et al., 2015). For example, Factor H (FH) is a soluble 
negative regulator of the alternative complement pathway that protects host cells 
from ‘self-attack’. It works in a feedback loop by recognising the increase of C3b, 
which opsonises bacteria for destruction by the complement system, and prevents 
excess generation of C3b by inhibiting C3 convertase activity (Figure 1.10) (Fallis, 
2013; (Józsi, 2017). 
Figure 1.10 – Simplified schematic to illustrate C3b and Factor H interactions. 
In the alternative pathway, hydrolysed C3 and factor B leads to the subsequent 
formation of C3 convertase C3bBb, which converts C3 to C3b. C3b is deposited on 
the bacterial cell surface, opsonizing it and marking it for destruction by the innate 
immune system (A). Factor H (FH) is a soluble negative regulator of this pathway 
and recognises the increase in C3b deposition on the cell. After recognition of the 
C3b increase, FH prevents further C3b production by inhibiting C3 convertase 




Because FH can prevent deposition of C3b, many bacteria have evolved the ability 
to bind directly to FH and so protect themselves from opsonisation. This is seen with 
Streptococcus pyogenes, which expresses a Factor H-binding protein (Fba) that can 
bind to both FH and Factor H-like protein (FH-L). Studies have shown that Fba and 
FH-L work in unison to facilitate the entry of S. pyogenes into epithelial cells, as well 
as preventing surface opsonisation and subsequent phagocytosis (Pandiripally et 
al., 2003). There is also evidence to suggest that the fibrillar M protein found on the 
surface of S. pyogenes may bind to FH and prevent C3b deposition (Gustafsson et 
al., 2013). It should be noted, however, that not all microbial interactions with FH 
confer a survival advantage. Some microbes, such as Group B Streptococcus 
(GBS), have been shown to bind to FH via surface proteins to promote complement 
degradation. GBS incubated with pure FH was shown to degrade almost 90% of 
C3b during in vitro work. This is highly advantageous to bacteria, as degradation of 
C3b results in minimal identification and destruction by the complement cascade 
(Maruvada et al., 2009). 
 
1.6.3.2 Evasion of neutrophils  
Some bacteria have evolved the ability to evade neutrophil responses, usually by 
avoiding recognition and/or clearance by the neutrophil (Brinkmann & Zychlinsky, 
2012). Some bacteria, in particular streptococci, can use peptidases to target 
neutrophil chemoattractants. For example, S. pyogenes expresses ScpA, which 
specifically degrades C5a and interleukin-8 (IL-8), which function to attract 
neutrophils to a site of infection. S. pneumoniae produces zinc metalloproteinase C 
(ZmpC), which is able to impair initial neutrophil rolling and decrease likelihood of 




nucleases, such as SWAN, which can degrade the DNA component of the NET, 
utilising Ca2+ and Mg2+ ions that have been sequestered from the host for optimum 
activity (Morita et al., 2014). 
 
1.7 Utilising TraDIS to define essential genes 
TraDIS, or Transposon Directed Insertion Site Sequencing is a novel, high 
throughput technique which allows for the generation and sequencing of a large 
transposon mutant library, which provides insight into gene essentiality within a 
bacterial genome. Transposons, or ‘jumping genes’ are DNA sequences which can 
change position within a genome, often resulting in mutations (Charbonneau et al., 
2017). Transposons are inserted into the bacterial chromosome (often via plasmids) 
and ultimately disrupt the genome at several points. Bacterial cells that contain 
these transposons are cultured, genomic DNA is sheared, and PCR amplification of 
the transposon-containing fragments is carried out. This data is then analysed using 
Illumina sequencing and mapped against the relevant bacterial genome (Dembek 
et al., 2015).  
Viable mutants will contain transposons that when inserted into a non-essential 
gene, will have no impact on the growth of the bacterium. However, when a 
transposon has inserted into an essential gene, causing disruption, this may be 
lethal for the bacterium. Bacterial colonies containing the transposons can be pooled 
together, providing a saturated transposon mutant library which permits the 
simultaneous sequencing of a large number of insertion sites. These mutant libraries 




for the relative fitness and potential essentiality of each gene to be determined 
(Dembek et al., 2015). 
This technique has been proven successful in identifying essential genes 
responsible for Strangles in horses, an infectious respiratory disease caused by 
Streptococcus equi (Charbonneau et al., 2017). Using this technique, essential 
genes required for the survival of S. equi in both growth media and human saliva 
were established by mapping the TraDIS transposon insertion readouts against the 
bacterial genome (Zhu et al., 2017). 
 
1.7.1 TraDIS and S. gordonii 
So far, the gene essentiality of S. gordonii is yet to be determined using TraDIS and 
currently very little is known about the ability of this streptococci species to survive 
and replicate within the bloodstream. Based on previous studies by Charbonneau 
et al., 2017, it was proposed that the gene essentiality of S. gordonii to survive in 
both growth media and human blood could be determined using the TraDIS 
technique, following an adapted protocol obtained by the Waller group in 
Cambridge. The information obtained from TraDIS would be vital in determining 
further the role of S. gordonii in both bacteraemia and Infective Endocarditis. 
Based on previous studies, it can be hypothesised that genes encoding for surface 
adhesins PadA, Hsa, SspA/SspB, CshA and CshB may be identified as essential 
for the survival of S. gordonii within the bloodstream (Haworth et al., 2017, 
Jakubovics et al., 2009 and McNab et al., 1996). However, additional genes would 




1.8 Project aims and objectives  
Viridans group Streptococcus bacteria, such as S. gordonii, account for 40-60% of 
IE cases. This is explained by their capacity to transit within the bloodstream from 
the oral cavity to the cardiovascular system, where they can then bind and activate 
platelets to trigger the formation of thrombotic vegetations on heart valves, leading 
to heart failure. For S. gordonii, this unwanted thrombosis has been shown to be 
mediated by two surface protein adhesins, Hsa and PadA. As an IE pathogen, it is 
clear, however, that S. gordonii must be able to utilise additional strategies to survive 
within the bloodstream and associate with cardiac endothelium. This aim of this 
project was therefore to investigate these potential mechanisms in more detail so 
as to provide a better understanding of the molecular basis of such processes. 
Specifically, the experimental objectives of this project were to:  
· Utilise a barcoded transposon directed insertion-site sequencing (TraDIS) system 
to define the genes that are critical for S. gordonii survival within human blood.  
· Investigate the role of specific S. gordonii surface proteins in promoting survival 
within human serum.  
· Interrogate proteomics data to determine the capacity for specific S. gordonii 





















2.1 Bacterial strains and growth conditions 
All bacterial strains used in this project are listed in Table 2.1. For S. gordonii, broth 
cultures were grown in Brain Heart Infusion broth supplemented with 0.5% (w/v) 
yeast extract (BHY). For maintenance on BHYN agar plates, BHY was 
supplemented with 0.5% (w/v) neopeptone and 15 g/L granulated agar. Where 
required, media were supplemented with 0.5 or 5 µg/ml erythromycin, 250 µg/ml 
kanamycin or 100 µg/ml spectinomycin. Broth cultures were routinely incubated for 
16 h at 37°C in reduced oxygen conditions. For E. coli, broth cultures were grown in 
Luria-Bertani (LB) broth and maintained on LB agar plates. Where required, media 
were supplemented with 0.5 or 5 µg/ml erythromycin.  Broth cultures were routinely 
incubated for 16 h at 37°C in aerobic conditions with agitation (220 rpm). 






Organism Strain Relevant genotype Reference or 
Source 






2864 S. gordonii DL1 ∆padA  Laboratory 
strain 
2930 S. gordonii DL1 ∆hsa  Laboratory 
strain 
2773 S. gordonii DL1 ∆padA∆hsa  (Jung et al., 
2015) 
2724 S. gordonii DL1 ∆padA::aad9-pMSP-
padA 
Haworth et al., 
(2017) 




2993 E. coli TG1 Host strain, RepA+ A. Waller, AHT 
3009 E. coli TG1 pGH9::ISS1-CA This study 
3014 E. coli TG1 pGH9::ISS1-CT This study 






2.2 Growth curves 
For growth curves, only wild-type S. gordonii was utilised, to give an indication of 
how long the bacterium takes to reach mid-exponential growth-phase. Overnight 
broth cultures were harvested by centrifugation (5000 g, 7 minutes) using a Rotina 
380 benchtop centrifuge (Hettich, Massachusetts, USA), washed once with PBS 
and bacteria resuspended in BHY to an optical density reading at 600 nm (OD600) 
of 1 (equivalent to approximately 109 CFU/ml). Suspensions were then diluted 1 in 
10 into fresh, pre-warmed BHY and incubated in a candle jar at 37°C. OD600 values 
were measured every 30 minutes over the course of 8 hours using a 
spectrophotometer. For some studies, alongside the OD600 readings, every hour, 
viable counts were determined. At each hourly time point, an aliquot (100 µl) of 
bacterial suspension was transferred to a 96-well microtitre plate and serially diluted 
1 in 10 into fresh BHY broth. Each dilution (3 x 20 µl) was plated onto BHYN agar, 
incubated for 24 hours at 37°C in a candle jar, and CFU/ml determined. 
 
2.3 Bacterial survival in human serum  
Overnight BHY broth cultures were sub-cultured into fresh BHY broth and incubated 
at 37oC for 3-4 hours until an OD600 of approximately 0.7 was obtained, 
corresponding to mid-exponential phase growth. Cells were harvested (5000 g, 7 
minutes), washed with PBS and resuspended in PBS to OD600 1. Bacterial cells then 
were serially diluted into PBS to obtain suspensions at approximately 104, 105 and 
106 CFU/ml. Adjusted bacterial suspensions (10 µl) were added to the wells of a 96-
well plate containing 90 µl human serum (CS500-100, TCS Biosciences, 




CO2, either with 80 or 150 rpm shaking. At each time point, aliquots (20 µl) of the 
bacteria/serum suspensions were removed, serially diluted in PBS and plated onto 
BHYN agar plates. The plates were incubated for 24 hours at 37°C and CFU/ml 
determined by viable count. During optimisation, these assays were also performed 
directly using bacterial cells harvested directly from overnight broth cultures. 
 
2.4 Neutrophil studies 
2.4.1 Isolation of human neutrophils 
Human blood (20-50 ml) was collected into vacutainer tubes containing K2EDTA 
and subsequently layered over Histopaque 1119 (Sigma, USA) and centrifuged (800 
g, 20 minutes) at room temperature. Plasma and peripheral blood mononuclear cells 
(PBMCs) were removed by vacuum aspiration, with the neutrophil layer transferred 
into a new 50 ml falcon tube. PBS (Ca2+ and Mg2+ free) and 0.2% (v/v) human serum 
albumin (HSA) was added and the suspension was centrifuged again (400 g, 10 
minutes). A Percoll gradient (Sigma, USA) of 85% to 65% was prepared in a 15 ml 
falcon tube, and the cell suspension was resuspended in PBS-0.2% HSA and added 
to the gradient. The gradient was then centrifuged (800 g, 20 minutes), after which 
the neutrophil layer was carefully removed and washed, centrifuged again (400 g, 
10 minutes) and resuspended in 2 ml PBS. Neutrophils were diluted 1:10, counted 
with an improved Neubauer haemocytometer, and subsequently seeded in well 







2.4.2 Preparation of bacterial biofilms for neutrophil assays 
Overnight broth cultures were harvested by centrifugation (5000 g, 7 minutes), 
washed once in PBS, and resuspended in 50:50 BHY:RPMI medium (Thermo-
Fisher, USA). Suspensions were then incubated at 37oC for 3-4 hours until OD600 
0.7 was reached (mid-log phase). Suspensions were washed once with PBS, 
resuspended in BHY/RPMI medium to OD600 1, and then 1 ml was added to wells 
of a 24-well plate containing 13 mm glass coverslips. The plate was incubated for 1 
hour at 37°C, 5% CO2 in humidified conditions. Wells were then washed twice with 
PBS to remove non-adherent bacteria, fresh BHY/RPMI was added, and the plate 
was incubated for a further 16 hours. Wells were then washed with PBS, fresh PBS 
was added, and the plate kept on ice until required. 
 
2.4.3 Immunostaining of Neutrophil Extracellular Traps (NETs) 
Bacterial biofilms were seeded with neutrophils (105 neutrophils per coverslip) for 2 
hours, before fixing with 2% paraformaldehyde for 20 minutes. Coverslips were then 
washed with PBS and all cells permeabilised with permeabilization buffer (0.5% 
Triton-X100 in PBS) prior to washing in triplicate. Coverslips were blocked with 3% 
bovine serum albumin (BSA) for 30 minutes at room temperature and then 
incubated for 2 hours with 50 µl of primary mouse anti-human 3D9 clipped histone 
antibody (unpublished antibody; Max Planck Institute for Infection Biology, Berlin, 
Germany) at a concentration of 1.413 mg/ml. After washing in triplicate, the 




dilution of 1:500 was added for 1 hour in the dark. Coverslips were washed three 
times, including DNA dye Hoechst 33342 (100 ng/ml; Sigma) in the first wash. After 
rinsing with distilled water, coverslips were mounted using Mowiol mounting medium 
onto microscope slides and sealed with clear nail polish for 30 minutes prior to 
visualisation by fluorescence microscopy. 
 
2.4.4 Neutrophil oxidative burst assay 
Bacteria required for the assay were harvested from overnight broth cultures by 
centrifugation (5000 g, 7 minutes), washed once in PBS, and resuspended in RPMI 
medium to OD600 1. Cells were then serially diluted in RPMI to obtain a suspension 
of approximately 5x106 CFU/ml, and added to 50% human serum for 15 minutes at 
37°C, 5% CO2 to induce opsonization prior to use. Neutrophils in 100 µl HBSS (with 
Ca2+ and Mg2+) supplemented with 0.025% HSA were seeded at a density of 105 
per well in a white 96-well plate. Horseradish peroxidase (HRP) and luminol were 
diluted 1:200 and 11 µl added to each well. The plate was then incubated for 15 
minutes at 37°C. Phorbol myristate acetate (PMA; 5 µl, 200 nM stock) was added 
as a positive control, and wells containing neutrophils only were used as a negative 
control. Opsonized bacteria (2 µl) were then added to the remaining wells at a 
multiplicity of infection (MOI) of 1:20 bacterial cells to neutrophils. 
Chemiluminescence was recorded over 4 hours at 2.5-minute intervals using a 







2.4.5 Ethical approval 
Anonymised blood from healthy donors was collected according to the Declaration 
of Helsinki. The study was approved by an NHS Research Ethics Committee and 
was agreed to be carried out at the University of Bristol. 
 
2.5 Vitronectin binding assay 
Multimeric vitronectin (Merck) was diluted in Tris-buffered saline supplemented with 
5 mM calcium chloride (TBSC) to a final concentration of 10 µg/ml and incubated 
with an equal volume of heparin (180 µg/ml; Sigma) or TBSC alone as control for 1 
hour at 37oC with gentle agitation (50 rpm). Bacteria were harvested from overnight 
broth cultures (5000 g, 7 minutes), washed with TBSC, resuspended in TBSC to 
OD600 1, and aliquots (50 µl) added to the wells of an Immulon 2HB 96-well plate. 
Following incubation at 37°C for 1-2 hours, unbound bacteria were removed by 
washing wells once in 200 μl TBSC, and non-specific binding sites were blocked 
with 3% (w/v) BSA in TBSC for 1 h at 37oC.  Wells were washed with TBSC before 
200 µl multimeric vitronectin ± heparin was added and incubated for 1 h at 37oC. 
Unbound protein was removed, and wells washed once in TBS (200 μl). Primary 
antibody (50 μl, mouse anti-human Vn; Santa Cruz Biotechnology, Texas, USA), 
diluted 1 in 1000 into Tris-buffered saline supplemented with 0.1% Tween-20 
(TBST), was added to the wells and incubated for 1 h at 37oC. Wells were washed 
twice in TBST before adding secondary antibody (50 μl, goat anti-mouse-HRP; 
Dako, Denmark) diluted 1 in 2000 into TBST containing 3% (w/v) BSA and 




in TBS. ELISA reagent (0.102 M Na2HPO4, 0.049 M citric acid, 0.012% H2O2, 3.7 
mM O-phenylenediamine; 50 μl) was added to wells and incubated in the dark for 
10 minutes at room temperature. The colorimetric reaction was then stopped by 
addition of H2SO4 (0.65 M, 50 μl), and levels of adhesion were quantified by 
measuring absorbance at 490 nm using an iMark Microplate Absorbance Reader 
(Bio-Rad, USA). 
 
2.6 TraDIS studies 
2.6.1 Preparation of competent E. coli cells 
An overnight LB broth culture (5 ml) of E. coli was sub-cultured 1:50 into fresh, warm 
LB broth and incubated at 37oC, 220 rpm for 1.5-3 hours until an OD600 of 
approximately 0.5 was obtained. Cells were harvested (3000 rpm, 15 minutes, 4°C), 
resuspended in 1/3 volume of ice-cold, sterile CaCl2 (50 mM), placed on ice for 20 
minutes and harvested again (3000 rpm, 15 minutes, 4°C). Cells were resuspended 
in ice-cold 100 mM CaCl2/15% glycerol and divided into 100 µl aliquots, which were 
snap frozen in liquid N2 and stored at -80°C. 
 
2.6.2 Transformation of E. coli  
Frozen aliquots of competent cells were thawed on ice and mixed with 2 µl pGhost 
(pGH9) plasmid DNA (obtained from the Waller group). Samples were incubated on 
ice for 30 minutes and then heat shocked at 42°C for 90 seconds. Cells were placed 




were incubated for 45-60 minutes at 37°C with shaking at 220 rpm. Samples were 
then serially diluted into LB broth, plated onto LB agar supplemented with 0.5 µg/ml 
erythromycin, and incubated at 37°C for 24-48 hours until potential transformants 
were visible. Successful transformants were confirmed by extracting plasmid DNA 
from overnight broth cultures using a QIAprep spin miniprep kit (QIAGEN, Germany) 
and visualising the DNA on 0.8% agarose gels. 
 
2.6.3 Preparation of electrocompetent S. gordonii cells 
S. gordonii is a naturally competent organism, however, in order to make the cells 
electrocompetent for electroporation the following protocol was carried out. An 
overnight BHY broth culture (10 ml) of S. gordonii was sub-cultured 1:100 into fresh 
BHY broth and incubated at 37oC for 3-4 hours until an OD600 of approximately 0.4 
was obtained. Cells were placed on ice for 10 minutes prior to harvesting (3000 g, 
10 minutes, 4°C) and then washed three times in sterile double-distilled water 
(ddH2O), and then three times in ice-cold wash buffer (0.3 M sucrose, 10% glycerol). 
Cells were resuspended in ice-cold wash buffer (0.5 ml) and 50 µl aliquots snap 
frozen in liquid N2 and stored at -80°C. 
 
2.6.4 Electroporation of competent S. gordonii cells 
Frozen aliquots of competent cells were thawed on ice and 1 mm electroporation 
cuvettes were pre-chilled. pGhost (pGH9) plasmid DNA was obtained using a 
Monarch Plasmid MiniPrep kit following manufacturer’s instructions (New England 




was added to the cells, suspensions transferred to the chilled cuvettes, and 
electroporated at 100 Ohms, 25 µF and 2.5 kV. BHY supplemented with 0.3 M 
sucrose was then immediately added to the cells and the sample placed on ice for 
10 minutes. Cells were incubated for 3 hours at 28°C for pHY304 or 37°C for pMSP. 
After incubation, samples were serially diluted into BHY broth and plated onto BHYN 
agar supplemented with 5 µg/ml erythromycin. Plates were then incubated at 37°C 
for 24-48 hours in a candle jar until potential transformants were visible. 
 
2.6.5 Transformation of S. gordonii 
An overnight BHY broth culture (10 ml) of S. gordonii was diluted 1:40 into fresh 
BHY broth and mixed with 1 µl competence stimulating peptide (CSP) 
(DVRSNKIRLWWENIFFNKK, 100 µg/ml stock; GenicBio, Taiwan), 100 µl foetal calf 
serum (FCS), and 2-5 µl (90-100 µg/ml) pGhost (pGH9) plasmid DNA (or ddH2O 
control). Samples were then incubated in a candle jar for 5 hours at 28°C. Samples 
were then serially diluted into BHY broth, plated onto BHYN agar supplemented with 
0.5 µg/ml erythromycin, and incubated at 28°C for 24-48 hours in a candle jar until 
potential transformants were visible. Successful transformants were confirmed by 
extracting plasmid DNA from overnight broth cultures using a QIAprep spin miniprep 
kit (QIAGEN, Germany) and visualising the DNA on 0.8% agarose gels. 
For initial work to determine whether transformation or electroporation was most 
efficient, laboratory plasmids pMSP and pHY304 were utilised, as plasmids obtained 
from the Waller group were low in abundance and it was critical to preserve as much 
as possible for TraDIS experiments. However, for all TraDIS preparation 




2.6.6 Preparation of DNA library for TraDIS 
A single S. gordonii transformant colony was used to inoculate BHY (10 ml) 
supplemented with 0.5 µg/ml erythromycin (BHY-erm) and incubated overnight at 
28°C in a candle jar. The culture was heat shocked at 40°C for 3 hours and then 
spread in 350 µl aliquots onto approximately 30 x 150 mm diameter BHYN plates 
supplemented with 0.5 µg/ml erythromycin. Plates were incubated at 37°C, 5% CO2 
under humidified conditions for 24 hours, and the colonies then harvested by 
scraping into BHY supplemented with 25% glycerol and stored as 500 µl aliquots at 
-80°C. An aliquot of this suspension (20 µl) was used to inoculate 20 ml BHY-erm, 
incubated at 37°C to OD600 0.5, and then split into 5 ml aliquots. Cells from each 
aliquot were harvested (10,000 g, 5 min) and pellets stored at -20°C ready for DNA 
extraction. 
 
2.6.7 DNA preparation for TraDIS 
DNA was prepared for next generation sequencing based on an adapted protocol 
by (Jung et al., 2015) In brief, DNA was extracted from library pellets using a 
GenElute Bacterial Genomic DNA Kit (Sigma, USA) and quantified using a high 
sensitivity Quant-iT dsDNA Assay Kit (Thermo-Fisher, USA). The DNA then 
underwent fragmentation, α-tailing and end repair, utilising an Ultra II DNA 
Library Prep Kit (New England Biolabs, USA). A Y-adaptor was generated in-house 
using adaptor primers 1Δ/2Δ (Table 2) and ligated to the fragmented DNA, and the 
fragments purified using AmPure XP beads (Beckman-Coulter, USA). Restriction 
digest with SmaI was used to cleave any plasmid pGh9:ISS1, and the DNA purified 




and indexing primer, as detailed in Table 2, according to the NEBNext Ultra II Q5 
Master Mix (New England Biolabs, USA) protocol. DNA was cleaned again using 
AmPure XP beads, the average fragment size estimated by gel electrophoresis, and 






Table 2.2 Primers used in this study 
 
 
2.7 Statistical analyses 
Statistical analyses were performed using GraphPad Prism or Microsoft Excel 
(Microsoft Office 365 Plus). Data shown are the mean ± standard deviation of the 
mean (SD) and, unless otherwise stated, experiments were performed in triplicate.  
Comparisons between two samples were performed using the Student’s 2-tailed 
unpaired t test or, for multiple samples, using an ANOVA followed by a Tukey post-










Adaptor primer 1Δ P-GATCGGAAGAGCACACGTCT  
 
Adaptor primer 2Δ ACACTCTTTCCCTACACGACGCTCTTCCGATC×T  
 
Indexing 
























S. gordonii survival in blood and 






S. gordonii is a common oral streptococcal species and also identified as an 
etiological agent of IE. The interaction between S. gordonii and platelets has been 
recognised as an important contributor in the pathogenesis of IE (Jung et al., 2015). 
Two key surface proteins found on S. gordonii, PadA and Hsa, mediate interactions 
with platelets via receptors GPIIbIIIa and GPIb, respectively (Gavillet et al., 2015). 
This enables S. gordonii to promote activation and aggregation of platelets at sites 
of roughened cardiac endothelium, generating a septic thrombus or vegetation 
(Jung et al., 2015). 
Binding of S. gordonii to ECM components exposed during tissue injury may also 
help to promote thrombus formation on damaged cardiac endothelium (Gavillet et 
al., 2015). Again, PadA and Hsa are implicated in this process. Previous studies 
have shown that PadA and Hsa may work in concert to mediate S. gordonii binding 
to fibronectin and vitronectin (Jung et al., 2015). As the disease progresses, host 
cells such as neutrophils may be activated and recruited to the site of infection. It 
has been suggested that activated platelets can promote the production of NETs, 
which further contribute to the generation of vegetations on the endocardium, in 
which bacterial cells are embedded (Gavillet et al., 2015). However, the capacity for 
S. gordonii to exacerbate this process during IE has not been explored.  
Alongside interactions with host cells at damaged heart valves, to contribute to IE, 
S. gordonii must survive within the hostile environment of the blood stream (Singh 
et al., 2010). Studies have demonstrated the capacity for strains of S. gordonii to 
evade deposition of complement opsonins (Alves et al., 2019) and survive within 
PMNs following adhesin-mediated phagocytosis (Jung et al., 2015). However, the 




Furthermore, S. gordonii has been shown to (modulate gene expression upon 
transition from the slightly acidic resting oral pH (6-6.5) to the neutral pH of blood 
(7.3) (Gavillet et al., 2015). This infers that S. gordonii may exploit a number of 
different strategies to persist within the blood stream. 
One recent approach that has been utilised to identify genes involved in blood 
survival for S. pyogenes, S. suis and S. agalactiae (Singh et al., 2010) is a high 
throughput next generation sequencing (NGS) technology known as Transposon 
Directed Insertion Site Sequencing (TraDIS). This technology allows transposon 
mutant libraries to be generated, which can then be utilised to identify bacterial 
genes that are required under a specific condition (Jung et al., 2015). Mutant 
libraries are prepared using plasmid pGh9::ISS1 (Figure 3.1), which carries 
barcoded variants of insertion element ISS1. This is a transposable element that 
inserts randomly into the bacterial chromosome with high efficiency and coverage 
(Maguin et al., 1996). Transposon libraries are grown under a specific experimental 
condition (e.g. in human blood), and the bacteria that are recovered are then 
sequenced and compared to the control library/inoculum. This generates a data set 
that provides information on the fitness and gene essentiality for that experimental 
condition (Gavillet et al., 2015). If mutants carrying transposon insertions have 
decreased in number, this indicates that the transposon has disrupted genes that 


















Figure 3.1 - Barcoded pGh9:ISS1 map. pGh9::ISS1 is a temperature-sensitive 
plasmid utilised for the delivery of ISS1. The ISS1 transposase is flanked by an 18 
bp inverted repeat and an 8 bp direct repeat. pGh9:ISS1 carries an erythromycin 
resistance gene (ermB) used to select for successful transposition, and the Gram-
positive temperature-sensitive replicase, RepA TS. Restriction enzyme sites in close 
proximity to ISS1 and its 2 bp barcode are shown. Reproduced from Charbonneau 
et al. (2017). 
 
The overall aim of the work presented in this chapter was to try and further 
understanding of the mechanisms by which S. gordonii can survive within the 
bloodstream and promote IE. Two main approaches were taken for this: 1) obtain a 
global overview of genes involved in blood survival utilising the TraDIS system, from 
which more targeted studies could then be developed, and 2) given their known 
association with IE, further investigate the potential functions of specific adhesins 
















Specifically, the key objectives of these studies were to: 
• Prepare transposon libraries in S. gordonii using the TraDIS system and 
identify the essential genome for this bacterium 
• Utilise the TraDIS transposon libraries to identify genes that significantly 
influence S. gordonii survival in human blood 
• Identify the potential role of S. gordonii adhesins PadA and Hsa in mediating 
S. gordonii survival in human serum 
• Further define the molecular basis of interactions between S. gordonii 
adhesins PadA or Hsa with ECM component vitronectin 
• Investigate the interactions of S. gordonii adhesins PadA and Hsa with 
neutrophils in the context of infective vegetation formation 
 
3.2 Results  
3.2.1 TraDIS studies  
3.2.1.1 Survival of S. gordonii in serum  
The first stage of these TraDIS studies was to optimise the parameters that would 
ultimately be used for the blood survival assays. Ethical constraints relating to blood 
collection within the School meant that access to healthy adult donors was limited. 
As such, optimisation was instead performed using human serum. Survival of S. 
gordonii in serum was determined over 6 hours. This incubation period was selected 
based on preliminary data within the group that indicated that viable bacteria could 
be detected over this time frame and was similar to other reported serum 




CFU were tested, and two different incubation conditions: 37°C, 5% CO2 with 
agitation at 150 rpm or 80 rpm (Trainor et al., 1999). 
For the most part, levels of bacterial survival across the time period correlated with 
inoculum (Figure 3.2). Fluctuations in CFU were seen over the 6 hours under all 
conditions, but there was a general trend for viable cell numbers to remain constant 
or decrease up to 1 log-fold over time, the latter particularly seen with the higher 
inocula (Figure 3.2). The main exception to this was seen when using a 104 CFU 
inoculum of mid-exponential phase cells incubated at 150 rpm, for which a slight 
increase in cell viability was recorded over the 6 hours (Figure 3.2D). Levels of 
bacterial survival were generally comparable for the two growth phases and for the 












Figure 3.2 – Impact of cell density, growth phase and levels of aeration on 
survival of S. gordonii in human serum over 6 hours. Bacterial cells harvested 
from overnight culture (A, B) or mid-exponential phase (C, D) were adjusted to 104 
(dots), 105 (stripes) or 106 (solid) CFU and incubated in human serum at 37°C, 5% 
CO2 for 0, 2 or 6 hours at 80 rpm (A, C) or 150 rpm (B, D).  At each time point, 
samples were serially diluted and enumerated by viable count. Data are presented 
as mean CFU ± SD; * P<0.05, *** P<0.001, **** P<0.0001 relative to equivalent 0-
hour time point, as determined by one-way ANOVA followed by Tukey’s post-hoc 

























































































3.2.1.2 Preparation of strains for transposon library generation  
Three different barcoded pGh9::ISS1 plasmids were kindly donated by the Waller 
group: pGh9-GA, -CT and -CA. These were first transformed into competent E. coli 
TG1 cells, using erythromycin resistance for selection. Plasmid DNA was then 
extracted from successful clones, quantified and visualised by gel electrophoresis. 
All three plasmids generated the expected agarose gel electrophoresis profile 
(Figure 3.3) and were therefore ready to be used for transposon library generation 
in S. gordonii.  
 
Figure 3.3 – Visualisation of barcoded pGh9::ISS1 plasmids extracted from E. 
coli. E. coli TG1 was transformed with plasmids pGh9-GA, -CT and –CA and 
plasmid DNA subsequently extracted and visualised by agarose gel electrophoresis. 





Standard transformation of S. gordonii is via serum-induced competence, which 
requires incubation periods of several hours at 37°C. However, the temperature-
sensitive pGh9::ISS1 plasmids require an incubation temperature of 28°C to 
maintain the plasmid in a Gram-positive host. The impact of adapting the serum-
induced competence protocol for use at a lower temperature on transformation 
efficiency was unknown. Consequently, alongside this approach, electroporation 
was also tested, since this method had been used successfully for these plasmids 
with other streptococcal species (Jung et al., 2015). 
 These studies were performed prior to the pGh9::ISS1 plasmids being received 
from the Waller group. As such, two alternative plasmids were selected to test these 
transformation protocols: pMSP7517 and pHY304. Plasmid pMSP7517 was used 
as it was known to transform well into S. gordonii, while pHY304 is another 
temperature-sensitive plasmid that had been used previously in Streptococcus 
agalactiae. 
Compared to transformation, electroporation seemed to be of much lower efficiency 
(Table 3.1). When using pMSP7517, 100-fold more colonies were generated by 
transformation than electroporation, while no colonies were seen when using 
pHY304 for electroporation compared to an average of 12 colonies for 
transformation. This indicated that transformation by serum-induced competence 








 Average number of colonies (1:100 dilution) 
Plasmid  Electroporation  Transformation  
pMSP7517 5 500 
pHY304 0 12 
ddH2O control  0 0 
 
Table 3.1 – Comparison of electroporation and transformation protocols in S. 
gordonii. S. gordonii DL1 cells were transformed with plasmids pMSP7517 or 
pHY304 by serum-induced competence (transformation) or electroporation. Data 
are presented as mean number of colonies on selective agar from a 1:100 dilution 
of bacterial suspension; n=2 (biological repeat). 
 
When selecting for transformants in S. gordonii using erythromycin resistance, an 
erythromycin concentration of 5 µg/ml is used routinely, and this was used in the 
pilot study shown in Table 3.1. However, studies using the TraDIS system in other 
streptococci had performed selection with 0.5 µg/ml erythromycin. Transformation 
of S. gordonii with the three barcoded pGh9::ISS1 plasmids was therefore 
performed using both concentrations for selection (Table 3.2). Both approaches 
generated transformants, but a higher number of colonies were recovered using 
selection with the lower erythromycin concentration of 0.5 µg/ml. Successful 
transformants were confirmed by recovery of plasmid DNA. These were then ready 






Table 3.2 – Transformation of S. gordonii with barcoded pGh9::ISS1 plasmids. 
S. gordonii DL1 cells were transformed with plasmids pGh9-CA, -GA or –CT or 
pMSP7517 (positive control) by serum-induced competence and transformants 
recovered on BHYN agar supplemented with 0.5 µg/ml or 5 µg/ml erythromycin. 
Data are presented as mean number of colonies on selective agar from a 1:100 
dilution of bacterial suspension; n=2 (biological repeat). 
 
3.2.1.3 Preparation of transposon libraries  
The steps undertaken to generate transposon libraries in S. gordonii using the three 
barcoded pGh9::ISS1 plasmids are summarised in Figure 3.4 and were based on 
an adapted protocol (de Mattos et al., 2004). In brief, barcoded pGh9::ISS1 
transformants were heat-shocked at 42°C to induce transposition (A) and DNA 
extracted and quantified from the resultant transposant populations (B-D). The DNA 
then underwent fragmentation, α-tailing and end repair (E), followed by purification 
 Average number of colonies (1:100 dilution) 
Sample  Selection at: 
5 µg/ml 0.5 µg/ml 
pGh9-CT 50 370 
pGh9-GA 50 500 
pGh9-CA 83 500 
ddH2O (negative control) 0 0 




(F). Purified DNA was then digested with SmaI to cleave the original pGh9::ISS1 
plasmid, followed by another round of purification and quantification. PCR utilising 
a specific ISS1 primer and indexing PCR primer was then performed to amplify 
regions that span the 5' end of ISS1 and the site of transposition in the S. gordonii 
genome (G). Amplicons were then purified, their size range estimated by gel 
electrophoresis, and quantified using qPCR (H). 
The anticipated DNA yield at the endpoint (step H) should be 0.5-0.8 nM. 
Unfortunately, the DNA yields from these studies were in the range of 0.005-0.008 
(Table 3.3) and thus 100-fold lower than anticipated. It is difficult to determine the 
cause of this discrepancy, but one possible point of failure may relate to the Y-
adapters, which were generated in-house at the University of Bristol. To overcome 
this issue and complete the studies, a visit to the Waller lab had been arranged for 
April 2020. However, due to the unforeseen Covid-19 pandemic, laboratories 




Table 3.3 – Quantification of transposon library DNA for next-generation 
sequencing. DNA concentration (nM) was calculated at step H (Figure 3.4) of 
preparing transposon libraries, using an average fragment length estimation of 600 
bp; n=2 (biological repeat). 
DNA yield (nM) 











Figure 3.4 – Schematic to illustrate the steps in preparing a TraDIS transposon 





3.2.2 Mechanistic basis of S. gordonii survival in blood  
3.2.2.1 Role of S. gordonii adhesins in serum survival 
 
Initial studies performed as part of the TraDIS work had indicated the capacity for 
S. gordonii DL1 to survive in human serum. Since S. gordonii surface proteins PadA 
and Hsa had previously been shown to engage with platelets within blood, it was 
hypothesised that these adhesins may also play a role in the survival of S. gordonii 
in serum. Based on the prior serum survival assay data, incubation conditions of 4 
hours at 37 oC, 5% CO2 with agitation at 150 rpm were selected, using a mid-
exponential phase inoculum of 105 CFU. 
To determine to roles of S. gordonii PadA and Hsa, survival of knockout mutants 
∆PadA and ∆Hsa, alongside the corresponding complemented strains +PadA and 
+Hsa, and a double knockout ∆PadA/Hsa strain, were compared to wild-type (Figure 
3.5). Heat-inactivated serum was used as a control. Numbers of wild-type S. 
gordonii cells increased 2-fold over the 4 hours, with significantly higher levels of 
survival seen in heat-inactivated serum relative to untreated serum. By contrast, no 
increase was seen for the single or double ΔPadA/Hsa mutants. This meant that 
removal of either PadA or Hsa significantly reduced the number of bacteria 
recovered after 4 hours relative wild-type, although no additional reduction was seen 
upon loss of both adhesins. Levels of survival were partially restored for the two 







Figure 3.5 – Survival of S. gordonii wild-type and PadA/Hsa mutant strains in 
human serum over 4 hours. Bacterial cells harvested from overnight culture were 
adjusted to 105 CFU and incubated in human serum at 37 oC, 5% CO2 for 0 or 4 
hours at 150 rpm. Heat-inactivated (H.I) serum was used as a control. At both time 
points, samples were serially diluted and enumerated by viable count. Data are 
presented as mean CFU ± SD; * P<0.05 or **** P<0.0001 relative to equivalent 0-
hour time point, or § P<0.05, §§§ P<0.001 relative to wild-type at 4 h, as determined 
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3.2.2.2 Interactions of S. gordonii with vitronectin  
Vitronectin is a glycoprotein found in serum, bone and the ECM. It plays an important 
role in coagulation and fibrinolysis following tissue injury (Gavillet et al., 2015). 
Vitronectin is also a regulator of the lytic pathway of the complement system, where 
it can inhibit C9 polymerisation and bind to the C5b-7 complex, preventing formation 
of the MAC (Alves et al., 2019). S. pneumoniae and S. pyogenes have been shown 
to utilise binding to vitronectin to promote adhesion to host cells and immune 
evasion (Paulsson et al., 2018; Cunha et al., 2010). Previous studies have shown 
that S. gordonii also has the capacity to bind to vitronectin, mediated by surface 
proteins PadA and Hsa (Haworth et al., 2017). (Cunha et al., 2010) 
Two regions of vitronectin have been found to be targeted by bacteria: sulphated 
tyrosine residues within the N-terminal domain and a C-terminal heparin-binding site 
(Singh et al., 2010) (Figure 3.6). Preliminary studies had demonstrated binding of 
S. gordonii to the N-terminal region of vitronectin. These studies therefore set out to 
determine if the C-terminal region was also targeted by S. gordonii and specifically 
PadA and/or Hsa. S. gordonii wild-type and ΔPadA/Hsa strains were immobilised 
on a microtiter plate and then incubated with multimeric vitronectin that had been 
preincubated with heparin or TBSC control. Wells were then washed and levels of 
bound vitronectin determined by ELISA. Corroborating previous data, high levels of 
binding to vitronectin were seen for wild-type S. gordonii, and these were reduced 
3-fold in the presence of heparin (Figure 3.7). Likewise, vitronectin binding levels 
were impaired almost 3-fold for both the ΔPadA and ΔHsa mutants relative to wild-








Figure 3.6 – Schematic of vitronectin indicating key domains. Domains 
identified at the N-terminus of vitronectin include a cell-binding motif (RGD) and a 
homologous region to growth-hormone intermediate somatomedin B (SMB). The 
connecting region (CR) connects the N-terminal with central domains, and contains 
acidic residues between aa 53-61, where two sulphated tyrosine residues bound by 
N. meningitidis are located at 56-59. The central and C-terminal domains contain 
homologous regions to plasma protein haemopexin (H1 and H2). The main heparin-
binding domain is HBD, composed of highly charged residues. Low affinity heparin 
binding also occurs at HB1 and HB2. Of these domains, bacteria primarily target 










Figure 3.7 – Binding of S. gordonii to vitronectin in the presence of heparin. 
Mid-exponential phase bacterial cells were immobilised in the wells of a 96-well 
microtiter plate and incubated for 1 h with multimeric vitronectin ± heparin. Levels of 
bound vitronectin were then quantified by ELISA. Data are presented as mean 
absorbance ± SD; *** P<0.001 relative to no heparin control, or §§§ P<0.001 relative 
to wild-type, as determined by two-way ANOVA with Tukey’s post-hoc test; n=3 








































3.2.3 S. gordonii interactions with neutrophils  
3.2.3.1 S. gordonii induction of NETs  
Neutrophils are amongst the first cells to arrive at a site of tissue injury and deploy 
a number of antimicrobial strategies, including the release of NETs to trap bacteria 
(Gavillet et al., 2015). However, oral Streptococcus, S. mutans, has been shown to 
exploit NETs to promote vegetation formation in IE via activated platelets (Alves et 
al., 2019). These vegetations then serve to trap and protect both bacteria and 
platelets. It was hypothesised that S. gordonii may elicit a similar effect to S. mutans 
during IE. To explore this, S. gordonii interactions with neutrophils were 
investigated. Again, given their association with IE, a potential role for S. gordonii 
adhesins PadA and Hsa was also considered. 
In the first instance, to investigate whether S. gordonii had the capacity to induce 
NET formation, S. gordonii wild-type biofilms were grown on glass coverslips for 16 
hours and then exposed to neutrophils for 2 hours. Samples were then fixed, 
immunostained for human histone H3 (to detect NETs) and DNA (to locate 
neutrophils) and visualised by fluorescence microscopy. PMA, a well-known 
stimulator of ROS production via activation of the NADPH oxidase complex, was 
selected as a positive control in these studies (Castanheira & Kubes, 2019), while 
unstimulated (no bacteria) neutrophils were used as a negative control. As 
anticipated, no NET formation was seen in the absence of neutrophil stimulation 







Figure 3.8 – Formation of NETs in response to PMA or no stimulus. Neutrophils 
were seeded onto blank coverslips in the absence (A) or presence (B) of PMA and 
incubated for 2 hours. Coverslips were fixed with 4% paraformaldehyde and 
immunolabelled for human histone H3 using an Alexa488 fluorophore (green) to 
label NETS and stained with DAPI for neutrophil DNA (blue). A ‘cobweb’ like 
appearance can be observed in image B with PMA, indicative of NET presence. 
Scale bar, 50 µm. 
 
When neutrophils were exposed to biofilms of wild-type S. gordonii, induction of NET 
formation was clearly visible (Figure 3.9A). To explore the potential role of PadA and 
Hsa adhesins in this process, studies were then repeated using biofilms of the 
ΔPadA and ΔHsa single and double knockout mutants. Induction of NET formation 
was seen for each of the mutant strains, to varying extents, although in all cases 









Figure 3.9 – Formation of NETs in response to S. gordonii. Biofilms of S. 
gordonii wild-type (A), ΔHsa (B), ΔPadA (C) or ΔPadA/Hsa (D) strains were 
incubated with neutrophils for 1 hour, fixed and then labelled with DAPI (neutrophil 
cell; blue) and Alexa488-conjugated anti-human histone H3 antibody (NETs; green). 
Representative images are shown. Scale bar, 50 µm. 
 
To try and better compare levels of NET induction across the S. gordonii strains, the 
NET to background ratio was quantified using ImageJ software, whereby the image 
was changed to 16-bit and black and white, and the NET area manually highlighted 
and calculated against the background area. This semi-quantitation approach 
confirmed the capacity for wild-type S. gordonii to induce NET formation compared 






was significantly lower for neutrophils exposed to biofilms of each of the PadA and 




Figure 3.10 – Semi-quantitation of NET induction by S. gordonii. Fluorescence 
micrographs from the NET induction assays were uploaded to ImageJ software and 
converted to 16-bit and black and white. NET area was then manually selected 
compared to background. Data are presented as the ratio of NETs to background 
(12 images per sample); **** P <0.0001 relative to wild-type, as determined by one-
way ANOVA with Tukey post-hoc test. n=12 (technical repeat from pooled data, 










































3.2.3.2 S. gordonii induction of neutrophil oxidative burst  
To investigate the capacity for S. gordonii to induce the neutrophil oxidative burst, a 
chemiluminescence-based assay for detection of reactive oxygen species (ROS) 
was utilised. Bacteria were opsonised with human serum and then incubated with 
neutrophils to give a multiplicity of infection (MOI) of 1:20. Horseradish peroxidase 
and luminol were added, and chemiluminescence then recorded over 4 hours. PMA 
stimulation of neutrophils was used as a positive control, and unstimulated 
neutrophils as a negative control. The results from this assay generated 
chemiluminescence curves (Figure 3.11A), which were then transposed to a bar 
graph using area under curve (AUC) analysis (Figure 3.11B).  
S. gordonii wild-type induced high levels of ROS production by neutrophils, which 
was higher than levels induced by PMA (Figure 3.11B). This was unexpected as 
PMA is a potent agonist of ROS production (Khan et al., 2014)The ΔPadA strain 
induced comparable levels of ROS to that of wild-type. By contrast, levels of ROS 
generated by neutrophils exposed to the ΔHsa strain were approximately 50% lower 
than for wild-type, and were reduced by approximately 75% for the ΔPadA/Hsa 














Figure 3.11 - S. gordonii induction of neutrophil oxidative burst. Bacterial cells 
were harvested from overnight cultures, opsonised with human serum, and 
incubated in a 96-well plate with neutrophils (MOI 1:20), horseradish peroxidase and 
luminol. Chemiluminescence was recorded over 4 hours. PMA stimulation of 
neutrophils and unstimulated neutrophils were used as positive and negative 
controls, respectively. Panel A shows the chemiluminescence curve and Panel B 
the area under curve analysis. For Panel B, data are presented as mean CFU ± SD; 
** P<0.01 and *** P<0.001 relative to wild-type, as determined by two-way ANOVA 
with Tukey’s post hoc-test; n=3 (biological repeat). 








































3.3.1 TraDIS studies  
The aim of these studies was to prepare a S. gordonii transposon library that could 
be exploited to gain a global overview of the genes that contribute to the survival of 
S. gordonii within human blood. Transposants using three different barcoded 
pGh9::ISS1 plasmids were successfully generated, but final yields of PCR 
amplicons covering the sites of transposition were significantly lower than required 
for next generation sequencing. The reason behind this remains unclear. However, 
based on levels of DNA obtained at the different stages, it seems likely that either 
the in-house preparation of the Y-adaptor or the final PCR amplification step using 
the ISS1 specific and indexing primers was the point of failure. A visit to the Waller 
group had been planned to troubleshoot and complete characterisation of the S. 
gordonii transposon libraries, before using them in studies involving human blood. 
Unfortunately, due to the circumstances imposed by the COVID-19 pandemic, this 
area of the investigation had to be terminated.  
 
3.3.2 S. gordonii survival in serum  
Human serum is obtained from blood plasma, after fibrinogen and other clotting 
factors have been removed. It contains a range of proteins, lipoproteins and 
nutrients, including a range of antimicrobial components. Key proteins found in 
serum that can mediate bactericidal effects include those of the complement 
system, so serum is often a good choice for studies relating to the complement 




provided evidence that wild-type S. gordonii was able to survive within human serum 
over a 6-hour period. Some reduction in the viable population was seen, indicative 
of bacterial killing, but this was minimal. Frozen serum stocks were used for this 
work and so it might be anticipated that higher levels of killing may have been 
observed in fresh serum, and certainly if using whole blood, in which the cellular 
components of the immune system would also be available. Nonetheless, 
bactericidal activity of serum has been shown to be maintained for up to three 
freeze-thaw cycles (O’Shaughnessy et al., 2012)In general, the high level of serum 
survival recorded here supports the concept of S. gordonii as an opportunistic 
pathogen that is able to persist within the blood stream and so promote systemic 
diseases such as IE. 
Heat-inactivation of serum is a technique used to investigate the role of serum 
proteins, namely the complement system, in mediating bactericidal effects. Higher 
levels of survival were seen for wild-type S. gordonii when incubated in heat-
inactivated serum compared to untreated serum, but the difference was relatively 
slight. This implies that S. gordonii may be adept at evading complement-mediated 
killing. In support of this, Alves et al. (2019) recently found that strains of S. gordonii 
isolated from systemic infections could evade deposition of complement proteins 
C3b/iC3b and so opsonophagocytosis by PMNs (Jung et al., 2015). 
Loss of either PadA or Hsa from the surface of S. gordonii reduced levels of serum 
survival relative to wild-type, while complementation increased survival. For the 
latter, survival was not fully restored to wild-type levels. This has been seen before 
with other phenotypes using these mutants (Haworth et al., 2017), and may reflect 
differences in adhesin expression levels when driven from the native promoter 




together, these data imply that both PadA and Hsa contribute to the capacity for S. 
gordonii to persist within serum. Since no additional reduction was seen in serum 
survival for the ΔPadA/Hsa double mutant compared to single knockout mutants, 
this suggests that PadA and Hsa may exhibit cooperative functions. Again, this has 
been proposed for PadA and Hsa in mediating biofilm formation and binding to 
fibronectin or vitronectin (Haworth et al., 2017), and correlates with the vitronectin 
data generated here. In these studies, PadA and Hsa were both shown to bind the 
heparin-binding site within the C-terminus of vitronectin. However, blocking with 
heparin did not ablate binding, indicating that these adhesins could also target an 
additional site(s). This correlates with previous, unpublished data indicating that a 
monoclonal antibody against the N-terminal region of vitronectin could also impair 
attachment of the ΔPadA and ΔHsa mutants. Thus, it is possible that both PadA and 
Hsa must engage vitronectin simultaneously for it to mediate its protective effects. 
As has been reported for other bacteria (Gavillet et al., 2015), this may then enable 
vitronectin to protect S. gordonii from complement-mediated killing, providing an 
additional immune evasion strategy that can be exploited by this bacterium. To 
further explore the cooperative function of PadA and Hsa in mediating interactions 
with vitronectin, binding of the ΔPadA/Hsa double mutant complemented with 
individual Hsa or PadA proteins could be tested. If concerted action by both 
adhesins is required, these mutants should behave alike to the individual knockout 
strains. 
Alongside a potential role in immune evasion, the capacity for S. gordonii PadA and 
Hsa to bind vitronectin could also enhance the capacity for S. gordonii to promote 
formation of infective vegetations during IE. Vitronectin is highly expressed within 




et al., 2010). Attachment of S. gordonii to this exposed vitronectin could then 
facilitate initiation of thrombosis at the site of injury.  
 
3.3.3 Interactions of S. gordonii with neutrophils 
In response to bacteria, neutrophils deploy a variety of antimicrobial strategies, 
including the expulsion of NETs and production of ROS. NETs appear as ‘cobweb’ 
structures, which are primarily composed of extracellular DNA, chromatin, elastase, 
proteinases and histones (Castanheira & Kubes, 2019). The observation of NETs 
within human infective vegetations has led to the proposal that NETosis in response 
to bacteria and platelet activation may contribute to thrombosis during IE (Jung et 
al., 2015). 
Strong induction of NETosis and neutrophil activation (as measured via ROS 
production) was seen for wild-type S. gordonii, even higher than that of the PMA 
control for ROS production. Thus neutrophil recruitment to sites of cardiac 
endothelial damage could exacerbate the capacity for S. gordonii to promote 
vegetation development. Furthermore, both PadA and Hsa contributed to these 
effects, albeit in seemingly different ways. For NETosis, loss of either PadA or Hsa 
significantly impaired NET formation relative to wild-type, again implying 
cooperative function between the two adhesins in this process. None of the mutants 
tested were ablated in NET induction, however, indicating that additional surface 
determinants of S. gordonii can induce NETosis. While visualisation of NETs was 
compelling, it is not the optimal method for quantification. For future studies, flow-
cytometry using antibodies against key components of the NET structure, such as 




to further verify the role of PadA and Hsa in NETosis induction, the set of 
complemented mutants could be tested, alongside knockout mutants of additional 
surface determinants. 
 
In contrast to NETosis, for ROS production, the PadA knockout mutant was 
comparable to wild-type, while a significant reduction was seen for the ΔHsa strain 
and this was further reduced for the ΔPadA/Hsa double knockout mutant. This infers 
potential redundancy of function between these two adhesins for neutrophil 
activation (i.e. both adhesins can independently induce neutrophil activation), but 
that Hsa has the dominant effect. As such, the presence of Hsa masks the activity 
of PadA, and this is only seen once Hsa has been deleted. (Haworth et al., 2017) 
To explore this further, future work could explore ROS production using the 
ΔPadA/Hsa double mutant complemented with individual Hsa or PadA proteins. It 
would be anticipated that restoration of either PadA or Hsa expression could 
increase levels of ROS production by neutrophils but to different levels. Again, even 
with the ΔPadA/Hsa double mutant, significant ROS production was seen. This 
indicates that additional surface determinants of S. gordonii can also induce 
neutrophil activation.  
Taken together, these data indicate that upon engagement by neutrophils, S. 
gordonii is a potent activator of NETosis and neutrophil activation. Moreover, 
adhesins PadA and Hsa play an important but not exclusive role in mediating these 
effects. Activated platelets release P-selectin and type 1 β-defensins that assist 
neutrophil activation. Since S. gordonii also has capacity to activate platelets, this 
raises the possibility that combined challenge of neutrophils with bacteria and 
platelets will exacerbate NET formation. Such a mechanism has been demonstrated 




studies could be repeated in which neutrophils are challenged with combinations of 
bacteria and platelets.  
 
3.4 Summary  
The overall aim of the work presented in this chapter was to try and further 
understanding of the mechanisms by which S. gordonii can survive within the 
bloodstream and promote IE. The key findings were as follows: 
 
• S. gordonii DL1 possesses the ability to survive within human serum for at 
least 6 hours, supporting its capacity to promote systemic disease 
• Adhesins PadA and Hsa contribute to S. gordonii serum survival 
• There is evidence to suggest that S. gordonii can evade complement-
mediated killing 
• One mechanism by which this might be achieved is via cooperative binding 
of PadA and Hsa to vitronectin, with both adhesins able to bind the N- 
(sulphated tyrosine residues) and C-terminal (heparin-binding) regions of 
vitronectin 
• S. gordonii can induce NETosis and ROS production (activation) when 
exposed to human neutrophils 
• Adhesins PadA and Hsa contribute to both of these the processes 
• Induction of NETosis, neutrophil activation and attachment to vitronectin are 
all mechanisms by which S. gordonii may promote the formation of infective 














Proteomic analysis of S. gordonii 














S. gordonii surface proteins Hsa and PadA have been extensively studied with 
regards to their interaction with platelets in the context of IE pathogenesis. Building 
on this work, preliminary studies performed within this group implied that Hsa may 
facilitate attachment of S. gordonii to human coronary artery endothelial cells 
(HCAEC), a function that could promote infective vegetation formation. However, 
the potential binding target was unknown. It was also hypothesised that Hsa and 
PadA may contribute to S. gordonii survival within the blood stream, which has now 
been supported by this study and the data presented in Chapter 3. To obtain a 
broader perspective of how Hsa and PadA may facilitate interactions of S. gordonii 
with blood components and endothelial cells, purified, native forms of these two 
adhesins bearing a C-terminal 6x histidine (His6) tag were used in pull-down assays 
with HCAEC lysates and platelet-rich and platelet-poor plasma (PRP; PPP). The 
captured proteins were then analysed by nanoscale liquid chromatography with 
tandem mass spectrometry (nanoLC MS/MS). These experiments were performed 
by a former MSc student, Punkita Lohiya, but the proteomic data had not been fully 
analysed.  
The way in which purified PadA and Hsa proteins were obtained was by engineering 
S. gordonii strains in which the LPxTG cell-wall anchor of PadA or Hsa had been 
replaced by a His6 tag. This meant that upon expression, these adhesins were 
secreted into the culture medium, from which they could then be purified using metal 
affinity-based chromatography. This approach had the additional advantage that the 
adhesins would carry any native posttranslational modifications, which could 




located within an operon with a number of downstream glycosyltransferase genes 
that are known to act on Hsa (Figure 4.1). To further explore the role of glycosylation 
in Hsa function, two S. gordonii strains were generated: one in which the entire 
operon was expressed, and one in which a transcriptional terminator was placed 
upstream of the gly gene. It was anticipated that the former would express native 
Hsa, designated Hsa6His(+), while the latter would express a non-glycosylated form, 
designated Hsa6His(-). Both forms were used in the pull-down assays with HCAEC 




Figure 4.1 – The secA2-secY2 locus showing genes encoding Hsa, core 
proteins and glycosyltransferases. 
The secA2-secY2 locus carries genes that encode Hsa, alongside accessory 
secretion proteins (asp1-5) (brown arrows) utilised for protein export and 
glycosyltransferases (gtfA, gtfB, gly and nss) (blue arrows), which are required for 
the glycosylation of Hsa. Reproduced from Bandara et al. (2016).  
 
Eluted protein-ligand complexes from the pull-down assays had been run on a 10% 
SDS-PAGE gel, excised and delivered to the University of Bristol Proteomics 
Facility. Trypsinisation was performed to generate a collection of peptides from each 
sample, which were then analysed by nanoLC MS/MS. With this technique, peptides 
are separated by reversed-phase nano liquid chromatography, where the protein 




continuously analysed by a mass spectrometer, which converts molecules within 
the eluent into a charged state. These molecules can then be analysed based on 
their molecular and structural characteristics; for example, the glycans within 
glycoproteins can be determined based on their ion content (Pitt, 2009; Rigbolt & 
Blagoev, 2010). 
 
The data were filtered using a 1% false discovery rate (FDR) cut off and were 
compared for each His-tagged protein with the control sample using the ‘area’ 
measurement, which corresponds to relative levels of a given protein in each 







Figure 4.2 – Summary of pull-down assays using purified Hsa and PadA with 
PRP, PPP or HCAEC lysates to generate raw data for proteomic analysis 
As the data arising from these former pull-down assays had not been fully analysed, 
the overall aim of the work presented in this chapter was to perform an in-depth 
analysis of these proteomics data to identify potential proteins within PRP, PPP and 





Specifically, the key objectives of these studies were to: 
• Use UniProt to identify potential proteins of interest on HCAEC or within 
PRP/PPP, based on cellular location or function, that may be bound by Hsa 
or PadA 
• Perform Ingenuity Pathway Analysis (IPA) to identify canonical pathways 
involved in Hsa or PadA interactions with proteins of interest on HCAEC or 
within PRP/PPP 
• Perform IPA to explore bio functions and their predicated activation state for 




4.2.1 Shortlisting of proteins identified in PRP and PPP 
Full lists of proteins bound by PadA or Hsa were initially exported to Microsoft Excel 
files. For PRP, 300 proteins were initially identified with Hsa6His(+), 306 with 
Hsa6His(-) and 292 with PadA6His. For PPP, 276 proteins were identified with 
Hsa6His(+), 268 with Hsa6His(-) and 247 with PadA6His. Lists were then further 
refined based on several parameters. The first parameter was the number of 
‘sample hits’ (PSMs), which indicates the number of times a sample was detected; 
the higher the value, the less likely the data are to be anomalous. A cut-off PSM 
value of 15 was used, below which results were discounted. Alongside this, each 
dataset was uploaded to UniProt, a website that provides a free, accessible 
resource of protein functional information based on uploaded proteomics datasets. 




and ‘status’. ‘Annotations’ refers to the number of times a given protein has been 
identified in previous users’ datasets and is indicated by a rating out of 5. For 
example, a 1/5 rating indicates very few to no datasets contained this protein, which 
may indicate contamination or an anomalous result. In contrast, a rating of 5/5 
indicates that several previous datasets have contained this protein, suggesting that 
it has been a protein of interest in previous research and samples. The cut off for 
annotations was set at a 3/5 rating, a middle ground between recognised proteins 
and those that may not have been identified in previous studies. ‘Status’ indicates 
whether a protein has been reviewed or unreviewed. Reviewed refers to a sample 
that has been identified by both another user and the software, indicating that this 
sample has been identified several times in previous datasets. Unreviewed refers 
to a sample that has only been identified by the software, and not manually identified 
by another user. In order to simplify the datasets for this study, unreviewed proteins 
were discounted, many of which did not have protein names or descriptions. 
Shortlisting based on PSM value, annotations and status for Hsa6His(+), Hsa6His(-) 
and PadA6His resulted in 258, 258 and 250 proteins, respectively, for PRP, and in 
222, 229 and 209 proteins, respectively, for PPP. 
A final parameter used for shortlisting based on the proteomics datasets was the 
logarithmic fold change (LogFC) value, which indicates protein binding intensity 
based on the control. For example, if LogFC = 0, the ratio of sample to control is 
one-to-one; however, if the sample is expressed twice as much as the control, the 
logFC is denoted as = 1. Based on this, samples with a LogFC of below 1 were 
excluded. This shortlisting ultimately left 41 proteins for Hsa6His(+), 40 with 
Hsa6His(-) and 44 with PadA6His with PRP, and 51 proteins for Hsa6His(+), 51 with 




Once the completed sets of shortlisted proteins had been generated, these were 
finally organised according to their intensity of binding to PadA6His, HsaHis6(+) or 
Hsa6His(-). This was again based on the LogFC value. The highest value for the 
shortlisted proteins in each dataset was identified, which was a LogFC of 12.14 for 
PRP and 11.98 for PPP. Based on this, binding intensity of the proteins was divided 
into three categories: + denotes proteins with a LogFC value of 1-4; ++, with a 
LogFC value of 5-8; and +++, with a LogFC value of 9-12. 
 
4.2.2 Proteins of interest identified in PRP and PPP 
One group of proteins that were bound by all three His-tagged proteins in both PRP 
and PPP, albeit to differing levels, were components of the complement system 
(Tables 4.1 and 4.2). These included complement proteins C2, C3, C4-A/C4-B, C5, 
C6 and C8. Within PRP, it was observed that Hsa6His (-) tended to demonstrate the 
highest binding affinity for these proteins, while in PPP, this was seen for Hsa6His 
(+). Within PRP, low level binding of complement protein C7 was also detected but 
was not observed in PPP. Alongside complement proteins, interactions with 
regulators of the complement system were recorded. All three adhesins exhibited 
binding to FH in both PPP and PRP (Tables 4.1 and 4.2). Within PPP, binding to 
complement factor 1 and protease C1 inhibitor was also detected, with particularly 
high affinity binding seen for Hsa6His (+). 
A second group of proteins that were shortlisted were those associated with the 
coagulation cascade (Tables 4.1 and 4.2). Within both PRP and PPP, binding by all 
three adhesins was detected for prothrombin, plasminogen and coagulation factors 




proteins in PRP, whereas in PPP, binding to fibrinogen (α-chain) was detected, 
particularly by Hsa6His (+). Within PRP (but not PPP), binding to negative regulator 
of coagulation, antithrombin-III, was seen, with PadA6His and Hsa6His (-) exhibiting 
comparable affinities. 
Another category of proteins that was shortlisted was ECM proteins. Fibrinogen has 
already been mentioned above. In PRP, vitronectin was identified and bound most 
strongly to PadA6His (Table 4.1). A similar trend was seen for plasminogen, 
although this was detected in both PRP and PPP. Interactions with lumican, a 
proteoglycan that can stabilise collagen fibrils (Shao et al., 2012) was detected in 
PPP, with the highest affinity interaction recorded for Hsa6His (+). 
Finally, binding to platelet integrin receptor GPIb was detected in PPP, with the 






Table 4.1 – Proteins of interest bound by Hsa or PadA in PRP 




(-)   
Hsa6His 
(+) 
Complement C2 Complement + +++ ++ 
Complement C3 Complement ++ ++ + 
Complement C4-A Complement ++ ++ + 
Complement C4-B Complement ++ ++ + 
Complement C5 Complement ++ ++ + 
Complement C6 Complement + +++ ++ 
Complement C7 Complement + + + 













+ + + 
Prothrombin Coagulation ++ ++ + 
Fibrinogen Beta Coagulation / ECM 
protein 
+++ +++ +++ 
Plasminogen Coagulation/ ECM 
protein 
+++ ++ + 
Heparin Co-factor 2 Coagulation +++ + ++ 
Antithrombin-III Coagulation 
Inhibition 




Vitronectin Cell Adhesion ++ + + 
 







Table 4.2 – Proteins of interest bound by Hsa or PadA in PPP 











++ ++ +++ 
Complement C2 Complement ++ ++ +++ 
Complement C3 Complement + ++ ++ 
Complement C4-A Complement + ++ +++ 
Complement C4-B Complement + ++ +++ 
Complement C5 Complement + + ++ 
Complement C6 Complement ++ + +++ 










++ ++ +++ 
Fibrinogen-alpha 
chain 
Coagulation / ECM 
protein 
+ + ++ 
Prothrombin Coagulation + + ++ 
Plasminogen Coagulation / ECM 
protein 
+ + ++ 















+ ++ +++ 
Heparin Co-factor 2 Coagulation + + ++ 
Lumican ECM Protein ++ ++ +++ 
GPIb (platelet) Platelet Adhesion + ++ ++ 
 
*Based on the protein LogFC values: +, 1-4, ++, 5-8; +++, 9-12 
$, ligand interaction with the bait protein weaker than the control 
 
4.2.3 Shortlisting of proteins identified in HCAECs 
The principal aim of the work with the HCAEC lysates was to try and identify 
potential receptors targeted by Hsa in mediating attachment by S. gordonii. 
Consequently, PadA6His was not included in this analysis. Initially, 618 proteins 
were identified for both forms of Hsa, but as for PRP and PPP, protein lists were 
then further refined based on the sample hits (PSMs). Here, a value of 5 rather than 
15 was used as the cut-off, as the overall PSMs values for HCAECs were generally 
lower than seen for plasma. Using this value to shortlist the proteins, this left 334 
proteins for both forms of Hsa. Proteins with LogFC values of 0.5 or below were also 
excluded. This left 52 proteins remaining for both forms of Hsa. Interestingly, 
throughout this screening, both forms of Hsa generated the same protein number 
after each shortlisting check-point. Based on the LogFC range of these shortlisted 
proteins, which was also much lower than seen for PRP/PPP samples, binding 




1.9, and +++ for values above 2.0. The dataset was further shortlisted using UniProt, 
to remove proteins based on status and annotation, using the same parameters as 
described above for PPP and PRP. As the purpose of this analysis was to identify 
potential HCAEC binding receptors for Hsa, a final shortlisting was performed using 
UniProt based on predicted/known cellular location. All proteins associated with 
organelles or the nucleus were removed, as the key focus of this study was to 
identify potential cell-surface associated proteins that may bind to Hsa. This gave a 
shortlist of 13 proteins, some of which were without an identity within the dataset. 
Those with identified protein and gene names are listed in Table 4.3. 
 
4.2.4 Proteins of interest identified on HCAECs 
ECM protein collagen type I was identified with significant hits recorded for both 
collagen α-2(I) chain and collagen type I- α1 chain. These were both bound more 
strongly by Hsa6His (+) than by Hsa6His (-). A similar trend in binding was 
demonstrated with vimentin, an intermediate filament protein commonly associated 
with endothelium exposed to shear stress, such as the cardiac endothelium  (Xu et 
al., 2004)a secretory form has been reported on the luminal surface of the blood 
vasculature (Xu et al., 2004).  
Both keratin type I and II were strongly bound by both Hsa6His (+), and Hsa6His (-). 
Keratin provides an adaptable scaffold to epithelial/endothelial cells, allowing them 
to sustain various mechanical stresses. However, keratin is more commonly 
associated with epithelial rather than endothelial cells (Traweek et al., 1993). The 
presence of keratin was due to contamination, and this is recognised as a common 




Cell junction proteins were also identified, with desmoglein-1 and ZO-2 showing high 
binding affinity to both forms of Hsa. These were shortlisted as similar proteins have 
been implicated in facilitating bacterial adhesion and subsequent colonisation 
(Costa et al., 2013). 
 
Table 4.3 – Proteins of interest bound by Hsa in HCAEC lysates 
Identified Protein Cellular Location Binding intensity* 
Hsa6His (-)   Hsa6His (+) 
Collagen alpha 2(I) 
chain 
Cytoplasm / ECM + ++ 
Collagen Type 1-alpha1 Cytoplasm / ECM + ++ 
Desmoglein-1 Cell Membrane ++ ++ 
Keratin Type I Cytoplasm/Nucleus +++ ++ 
Keratin Type II Cytoplasm ++ +++ 
Tight Junction ZO-2 Cell Junction ++ +++ 




*Based on the protein LogFC values: +, 0.5-1.0; ++, 1.1-1.9; +++, above 2.0 
 
4.3 Ingenuity Analysis Pathway  
Ingenuity Pathway Analysis (IPA) is an advanced, web-based bioinformatics tool 
from QIAGEN, which analyses proteomics data and gene expression patterns using 




toxicology or microRNA sequencing, and all data can be transferred to Microsoft 
Excel for ease of use. IPA provides information on detected genes, including cellular 
location, name and drug interactions. In addition, a main results page lists several 
output functions of IPA, to include canonical pathways, diseases and function, and 
upstream regulators (Jiménez-Marín et al., 2009; Krämer et al., 2014). 
In this study, IPA was applied to the original pull-down assay proteomics data to try 
and identify specific interactions that were occurring at the molecular level between 
Hsa or PadA with proteins within PRP and PPP. Two aspects of analysis were 
explored in this study – canonical pathways and biological (bio) functions. Canonical 
pathways are pathways that demonstrate the relationship between the genes 
identified in a given experiment. There are usually two key pathway types identified, 
metabolic and signalling, which are grouped in order of activation intensity (i.e. how 
much these pathways are activated after protein-ligand binding occurred). Bio-
functions indicate biological functions that the genes (and pathways) are associated 
with, in both a health and disease state. Bio-functions are usually grouped based on 
how much a function is activated; in this case, during or after the interaction between 
PRP/PPP proteins and Hsa or PadA.  
 
4.3.1 Shortlisting of canonical pathways 
Canonical pathways were recorded as intensity based on a -log p-value. The 
activation status of these pathways was predicted using the IPA Upstream 
Regulator Analysis Tool, which calculates a regulation Z-score and an overlap p-
value, which is based on the number of known target genes of interest in the 




the IPA system. The pathways were arranged in descending order (highest-lowest) 
of -log(p) value, with values of 5 or below discarded, leaving 17 pathways. From 
these 17, pathways were further refined by identifying those associated with host-
pathogen interactions using the search function, so as to exclude random pathways 
such as those associated with host-drug interactions. This gave the pathway 
shortlists shown in Tables 4.4 and 4.5. 
 
4.3.2 Predicted canonical pathways 
In line with the initial proteomic analyses for both PPP and PRP, two of the pathways 
that gave the highest intensity values were those involved in coagulation and the 
complement system. A third, and indeed the most significant of the pathways 
identified, was the acute phase signalling response. This is a complex, early defence 
system that is activated by trauma, infection and inflammation. It is non-specific but 
is a major component of the innate immune response that aims to clear pathogens 
and encourage healing (Chaudhry & Babiker, 2018). For both PRP and PPP; 
Hsa6His (-), Hsa6His (+) and PadA6His generated comparable response levels.  
The coagulation and complement system pathways were also activated comparably 
by Hsa6His (-), Hsa6His (+) and PadA6His in both PRP and PPP.  
Two other pathways of interest identified during this analysis were the extrinsic and 
intrinsic prothrombin activation pathways. These pathways are associated with the 
clotting cascade, or haemostasis. The intrinsic pathway is the longer pathway that 
begins with activation of Factor XII after exposure to endothelial collagen, which 




occurs once blood vessel damage has occurred. Endothelial cells release tissue 
factor, which activates factor VII to factor VIIa, ultimately activating Factor X to factor 
Xa, which is where the extrinsic and intrinsic pathways merge (Figure 4.3) (Roy et 
al., 2016). The extrinsic and intrinsic pathways were activated comparably by all 




















Figure 4.3 – The intrinsic and extrinsic prothrombin activation pathways, 
leading to the ‘common pathway’.  The intrinsic pathway is the longer pathway, 
beginning with activation of factor XII into XIIa after endothelial damage has 
occurred. Factor XIIa activates XI to Factor XIa, which then activates Factor IX to 
Factor IXa. Factor IXa subsequently activates Factor X into Factor Xa. The extrinsic 
pathway is activated by tissue factor, released after endothelial damage has 
occurred. Tissue factor activates Factor VII to Factor VIIa, which activates Factor X 
into Factor Xa. At this point, both pathways meet and merge, known as the common 
pathway. This pathway begins at Factor X, which is activated to Factor Xa. Factor 
Xa activates prothrombin into thrombin, which subsequently activates fibrinogen into 
fibrin. Thrombin is also involved, activating other factors in the intrinsic pathway 
(Factor XI) alongside cofactors. Fibrin subunits ultimately form fibrin strands, 
eventually resulting in a fibrin clot. Red arrows represent some of the key 
conversions associated with clot formation, of which S. gordonii may interact with, 
based on the findings within this study. Reproduced from Chaudhry & Babiker 





Table 4.4 – Canonical pathways identified for the interactions of Hsa and PadA 
with PRP proteins 
 Intensity (log-p) 
Pathway Hsa6His (-) Hsa6His (+) PadA6His 
Acute Phase Response 
Signalling 
47.7 47.2 46.8 
Coagulation system 31.4 32.7 32.6 
Complement system 26.5 27.7 25.4 
Extrinsic prothrombin 
activation pathway 
17.6 19.4 18.2 
Intrinsic prothrombin 
activation pathway 
17.6 18.8 18.4 
 
Table 4.5 – Canonical pathways identified for the interactions of Hsa and PadA 
with PPP proteins  
 Intensity (log-p) 
Pathway Hsa6His (-) Hsa6His (+) PadA6His 
Acute Phase Response 
Signalling 
42.7 45.9 44.7 
Coagulation system 29.2 29.2 29.4 
Complement system 30.8 33.0 31.0 
Extrinsic prothrombin 
activation pathway 
20.0 17.5 20.1 
Intrinsic prothrombin 
activation pathway 






4.3.3 Shortlisting of bio-functions 
For all samples, an average of 502 bio-functions were initially identified. These were 
then divided into activated or deactivated functions. Only 2 bio-functions across all 
samples appeared as deactivated. These were related to cell death and removed 
from further consideration. For those bio-functions that were activated, bio-functions 
were organised according to their activation z-score. Functions with a z-score of 4 
or below were disregarded, as these functions did not give a predicted activation 
state and appeared to be associated with host-drug interactions, rather than host-
pathogen interactions. Bio-functions were then further refined based on potential 
relevance to bacteraemia and the pathogenesis of IE and included bio-functions 
associated with the immune response, host-pathogen interactions and the 
cardiovascular system. These shortlisted bio-functions are listed in Tables 4.6 and 
4.7. 
 
4.3.4 Predicted activation state of bio-functions 
Proteins within PRP were activated in bio-functions relating to cellular movement, 
endothelial cell movement and activation, and cardiovascular cell movement by all 
3 His-tagged adhesins. In addition, these three proteins all triggered activation of 
components of the inflammatory and innate immune responses, such as 
chemotaxis, phagocytosis, degranulation of phagocytic cells, and immune cell 
activation. In addition, Hsa activated functions associated with neutrophil adhesion 
and activation, and the activation of macrophages and APCs, although the latter 




For the proteins in PPP, a generally similar profile of activated bio-functions was 
identified, with both Hsa and PadA associated with endothelial cell activation, 
chemotaxis and engagement of phagocytic cells. Again, neutrophil activation and 
the activation of macrophages and APCs was seen for Hsa6His(+). Platelet 
adhesion function was identified for PadA, which was not identified in PRP, but in 






Table 4.6 – Bio-functions and activity state identified for interactions of Hsa 
or PadA with PRP proteins 
  Predicted activation state 
Bio Function Function Hsa6His (-) Hsa6His (+) PadA6His 
Cellular movement Migration + + + 
Chemotaxis Chemotaxis + + + 
Infectious disease Infection of leukocyte 
cell lines 












+ + + 
Inflammatory 
response 
Host cell immune 
response 
+ + + 
Degranulation Cell degranulation + + + 
Degranulation Degranulation of 
phagocytic cells (i.e. 
neutrophils) 
+ + + 
Cell signalling Granulocyte 
activation 
+ + $ 
Cell-cell response Neutrophil adhesion + + $ 
Cell-cell response Granulocyte 
adhesion 
+ + $ 
Synthesis Nitric oxide synthesis + + $ 
Inflammatory 
response 
Phagocytosis + + + 
Cellular movement Phagocyte 
movement 
+ + + 
Cellular movement Leukocyte movement $ + + 
Cellular movement Fibroblast movement + + $ 
Cellular assembly Fibrogenesis + + $ 
Cellular response T lymphocyte 
proliferation 
$ + $ 
Cellular response Activation of antigen-
presenting cells 
$ + $ 
Cell signalling Macrophage 
activation 
$ + $ 
Cell maintenance Internalisation of 
bacteria 
+ + $ 





Table 4.7 – Bio-functions and activity state identified for interactions of Hsa 
or PadA with PPP proteins  
  Predicted activation state 
Bio Function Function Hsa6His (-) Hsa6His 
(+) 
PadA6His 
Cellular movement Migration + + + 
Cell-cell response Platelet adhesion $ $ + 
Infectious disease Infection of 
leukocyte cell lines 












$ + $ 
Inflammatory 
response 
Host cell immune 
response 
+ + + 
Degranulation Cell degranulation + + $ 
Degranulation Degranulation of 
phagocytic cells 
(i.e. neutrophils) 
+ + + 
Cell signalling Granulocyte 
activation 
$ + $ 
Synthesis Nitric oxide 
synthesis 
$ + $ 
Cellular response Organization of 
cytoskeleton 
$ + $ 
Inflammatory 
response 
Phagocytosis + + + 
Cellular movement Phagocyte 
movement 
+ + + 
Cellular movement Leukocyte 
movement 
$ + + 
Cellular movement Fibroblast 
movement 
$ + $ 
Cellular response Respiratory burst $ $ + 
Cellular assembly Fibrogenesis $ + $ 
Cellular response T lymphocyte 
proliferation 
$ + $ 
Cellular response Activation of 
antigen-presenting 
cells 
$ + $ 
Cell signalling Macrophage 
activation 
$ + $ 
 





4.4.1 Interactive proteins identified in plasma 
A major group of proteins bound by both Hsa and PadA within plasma were 
members of the complement system. Engagement of this immune system was 
further supported by the IPA analysis. Of particular note was the identification of 
proteins C3b and Factor H, which are associated with the opsonisation of bacterial 
cells. C3b labels bacterial cells for removal, whereas Factor H acts as a negative 
regulator of the complement system and drives the proteolytic degradation of C3b. 
Thus, it may be possible that engagement of Factor H by Hsa and PadA may 
promote complement evasion and therefore survival of S. gordonii within blood. A 
similar mechanism is seen with S. suis, which binds to Factor H as a cofactor in the 
presence of complement factor I. This leads to the degradation of C3b, thus 
preventing opsonophagocytosis. In addition, this recruitment enhances the capacity 
of S. suis to adhere to both epithelial and endothelial cells, although the exact 
mechanism is still unknown (Roy et al., 2016). The binding of Hsa and PadA to 
Factor H identified here may also correlate with the findings of Alves et al. (2019), 
for which blood isolates of S. gordonii showed lower levels of C3b/iC3b deposition 
and subsequent opsonophagocytosis relative to other strains (Alves et al., 2019). 
To confirm these interactions and the potential protective effects of adhesion to 
Factor H by S. gordonii, FACS could be used to quantify relative levels of surface-
bound Factor H vs. C3b for wild-type S. gordonii and the Hsa/PadA knockout strains 
(Ermert et al., 2013). This technique could also be employed to confirm adhesion to 
the other complement proteins identified in this study to S. gordonii.  
Another complement protein identified was C4b. This protein is derived from C4 




pathways of the complement system, where it can also covalently attach to bacterial 
cell surfaces after activation (Cray et al., 2009). Protective effects via bacterial 
binding to C4b-binding protein, an inhibitor of the classical pathway, have been 
reported but not for binding C4b directly. This outcome may therefore simply be 
indicative of the innate immune response functioning to promote bacterial clearance 
via opsonophagocytosis (Cray et al., 2009) 
Complement proteins C5, C6 and C8 were also bound by both Hsa and PadA. 
These complement proteins form the membrane attack complex (MAC), along with 
C7 and C9, which were not reliably identified in this study. Gram-positive bacteria 
such as S. gordonii are generally resistant to MAC killing, as the thick peptidoglycan 
layer of the cell wall makes it difficult for the MAC pore to form within the underlying 
cell membrane (Cray et al., 2009). It is possible then that binding of S. gordonii to 
these complement proteins may not significantly impact survival within the blood 
stream. 
A general trend that was seen throughout these datasets was that Hsa6His (+) 
appeared to bind better to the complement proteins (and most of the interactive 
proteins) in comparison to Hsa6His (-) in PPP but not in PRP. This may indicate that 
Hsa preferentially targets platelets in blood, so this interaction dominates in PRP. 
However, when platelets are removed in PPP, binding to complement and 
coagulation proteins can then be detected. This aligns with a study by Deng et al. 
(2014), in which the selective targeting of platelet sialoglycoproteins by S. gordonii 
surface adhesins, including Hsa, was identified. This provided evidence that oral 
streptococci can preferentially recognise platelets, despite the availability of other 
sialoglycoproteins found within whole blood, with platelets then serving to deliver 




IE pathogenesis (Liesenborghs et al., 2020). The differences in binding profiles 
between Hsa6His (+) and Hsa6His (-) in PRP and PPP also imply that glycosylation 
of Hsa may be important for its interactions with platelets and may enhance the 
efficiency of Hsa binding to target proteins in general. 
Alongside complement, two other major groups of interactive proteins identified in 
plasma were those associated with the coagulation cascade and with the ECM. 
Evidence of triggering the coagulation cascade was also provided by the IPA 
analysis, and links with the capacity of S. gordonii to induce clot formation, both 
during vegetation development during IE and for other systemic conditions such as 
disseminated intravascular coagulation. Of the ECM proteins identified, the 
strongest binding capacity for S. gordonii proteins Hsa and PadA was seen with 
fibrinogen beta. Within PRP, vitronectin binding was also identified, most strongly 
with PadA. This supports the data presented as part of this project in Chapter 3 and 
corroborates the study of Haworth et al. (2017), in which binding of PadA to 
vitronectin was first proposed. It may also indicate that platelets were a major source 
of vitronectin, which correlates with the known capacity of S. gordonii to activate 
platelets (Cray et al., 2009) 
In relation to blood survival, binding to both fibronectin and vitronectin have been 
shown to enable other streptococcal species to evade complement-mediated killing. 
S. pyogenes achieves complement evasion by recruiting fibrinogen to its surface, 
which has been proposed to prevent phagocytes from recognising deposited C3b 
and also inhibits the formation of the C3 convertase within the classical and lectin 
complement pathways (Liesenborghs et al., 2020). In addition, S. suis, a major 
contributor to septicaemia and meningitis, possesses novel fibrinogen binding 




and also prevents complement deposition on the bacterial cell surface, thus 
preventing opsonisation (Hatayama et al., 2018). It is possible then that by binding 
fibrinogen and vitronectin, when in the blood stream, Hsa and PadA may serve to 
protect S. gordonii from complement-mediated killing (Cray et al., 2009). As already 
discussed, vitronectin on the bacterial cell surface prevents the association of C9 
with C5-7, meaning that the MAC cannot be formed. Binding of S. gordonii PadA to 
vitronectin could also promote complement evasion via this mechanism 
(Liesenborghs et al., 2020).  
In addition to complement evasion and overall survival within blood, the binding of 
S. gordonii via Hsa and PadA to fibronectin and vitronectin may also promote 
vegetation formation during IE. In native IE, this process is initiated at sites of 
damaged cardiac endothelium in which components of the ECM are exposed. The 
capacity to target fibrinogen and vitronectin may enable S. gordonii to attach to the 
damaged, roughened cardiac surface, before recruiting circulating platelets to 
initiate thrombosis (Hatayama et al., 2018). 
 
4.4.2 Interactive proteins identified in HCAEC lysates 
Collagen was a prominent component that was bound by Hsa within HCAEC 
lysates. Previous studies on S. gordonii adhesins SspA and SspB have indicated 
their ability to adhere to collagen; a mechanism that enables S. gordonii to invade 
dentinal tubules (Cray et al., 2009). Other collagen binding proteins have also been 
found on the surface of S. gordonii, such as Sgo0707, which binds to type I collagen 
and oral keratinocytes, and CbdA, which binds to collagen within root canals ex vivo 




for Hsa to bind type I collagen (Freires et al., 2017). Cnm, expressed by another IE 
pathogen, S. mutans, is a collagen and laminin-binding protein that has been shown 
to readily bind to collagenous fibrils on damaged valvular tissue (Costa et al., 2013). 
Thus, it is possible that attachment of S. gordonii to collagen, including via Hsa, may 
represent a key mechanism that can promote vegetation development on damaged 
heart valves. To confirm this hypothesis, a fluorescence-based assay could be 
carried out, in which S. gordonii strains lacking Hsa are GFP-labelled and examined 
for their capacity to bind to purified type I collagen and to heart valves ex vivo 
(Hatayama et al., 2018). As a protein associated with collagen scaffolds, it is 
possible that S. gordonii attachment to collagen fibrils also explains why lumican 
was identified as an interactive protein (albeit in PPP). 
A second HCAEC protein that was bound by Hsa was vimentin. Intermediate 
vimentin filaments are found in abundance in endothelial tissue exposed to shear 
stress, such as cardiac tissue (Schnittler et al., 1998). Thus, this protein might be 
expected to be exposed upon damage to cardiac endothelium. Furthermore, a 
secretory form of vimentin has been reported on the luminal surface of the blood 
vasculature (Xu et al., 2004). Adhesion of Hsa to vimentin may therefore represent 
a potential mechanism that enables S. gordonii to attach to both damaged and intact 
cardiac endothelium.  
The other proteins of interest identified within the HCAEC cell lysate were those 
associated with endothelial cell junctions, namely tight junction protein ZO-2 and 
desmosome constituent desmoglein-1. Cell-cell and cell-matrix junctions are 
essential for maintaining polarized endothelium whilst preventing entry of pathogens 
(Cray et al., 2009)These junctional complexes comprise tight junctions, adherens 




for bacterial attachment and entry into the cell. For example, desmoglein-1 has 
previously been indicated as a key target for bacteria such as S. aureus to facilitate 
adhesion to and subsequent invasion of host cells (Sokolovska et al., 2012). Thus, 
Hsa may exploit similar mechanisms to mediate S. gordonii adherence or invasion 
of cardiac endothelium. To explore this in more detail, S. gordonii wild type and 
∆Hsa mutant could be tested in cell adherence or invasion assays using polarized 
endothelial cells with either intact or disrupted cell junctions (Liesenborghs et al., 
2020), or in the presence of specific inhibitors (e.g. blocking antibodies) against ZO-
2 and desmoglein-1. 
In general, higher binding to HCAEC lysate proteins was seen with Hsa6His(+) 
compared to Hsa6His (-). This implies that glycosylation might be required for the 
most effective binding of Hsa to HCAEC proteins and/or that posttranslational 
modification is needed for correct protein conformation and therefore function. It 
should also be noted that direct binding to specific endothelial cell receptors was not 
identified, but rather to ECM, cell junction or surface-associated proteins. This 
correlates with the association of S. gordonii with native valve IE, for which the 
initiating factor is suggested to be the presence of a damaged or roughened 
endothelium for bacterial attachment and vegetation formation. Nonetheless, one 
disadvantage of this assay approach was the use of whole cell lysates, which meant 
that cytoplasmic proteins dominated the samples. It is possible that, if this assay 
was repeated using a cell-surface preparation of HCAECs, alternative receptors 






4.4.3 Additional pathways/responses identified  
Acute phase response (APR) signalling was the pathway that generated the highest 
intensity via IPA analysis of plasma interactive proteins. This is a core component 
of the innate immune response and can be activated by a multitude of factors, such 
as trauma or stress (Cray et al., 2009). Another key trigger of the APR is bacterial 
presence, and APR proteins can help to trap microorganisms and activate the 
complement system (Cray et al., 2009). These data likely indicate, therefore, the 
induction of the host immune response upon entry of S. gordonii into blood. This is 
further supported by the identification of macrophage activation, fibroblast 
movement, T-lymphocyte proliferation and degranulation of phagocytic cells from 
the IPA analysis. Moreover, both Hsa and PadA appeared to be specific triggers of 
the immune response. Again, this correlates with data presented in Chapter 3, in 
which PadA and Hsa were implicated in neutrophil activation and induction of 
NETosis. 
Endothelial cell activation was identified for both Hsa and PadA via IPA analysis, 
especially within the PRP sample. This is particularly pertinent to the pathogenesis 
of IE, as activated endothelial cells change from a normal anti-coagulant state into 
a prothrombotic state, in which they drive thrombosis via the recruitment of fibrin 
and platelets, and the release of tissue factor to activate the extrinsic coagulation 
pathway (Liesenborghs et al., 2020). Activation of fibrinogenesis is also noteworthy, 
as this process is associated with vegetation formation. Lesions found within IE 
patients are often comprised of a platelet and fibrin clot, enriched with other immune 
cells and bacteria (Jung et al., 2015). The potential for Hsa and PadA to induce 
endothelial cell activation and fibrinogenesis thus represent additional mechanisms 




Because the proteomic data were derived from a single pull-down assay, there were 
gaps in the data sets due to anomalous or unsuccessful analysis (as denoted by “$” 
in the relevant tables). To obtain a more complete data set and to further validate 
the role of Hsa and PadA in the interactions and pathways identified here, this 
experimental work and analysis should be repeated at least in duplicate. 
Furthermore, in order to explore the potential interaction networks in more depth, 
additional independent samples should be collected and analysed. 
 
4.5 Summary  
The overall aim of the work presented in this chapter was to perform an in-depth 
analysis of the proteomics data arising from previous pull-down assays to 
identify potential proteins within PRP, PPP and on HCAEC that may be engaged by 
S. gordonii adhesins PadA and Hsa. The key findings were as follows:  
• PadA and Hsa bind strongly to complement proteins but also to proteins 
such as Factor H, fibrinogen and vitronectin, which may serve to protect S. 
gordonii from complement-mediated killing  
• PadA and Hsa bind strongly to components of the coagulation cascade and 
promote endothelial cell and prothrombin activation pathways; functions that 
could enable S. gordonii to drive the unwanted thrombosis associated with 
IE  
• Binding of Hsa to exposed ECM proteins such as collagen or lumican, or to 
junctional complex constituents, may facilitate S. gordonii attachment to 




• In addition to those interactions listed above, IPA analysis indicated the 
capacity for S. gordonii Hsa and PadA adhesins to induce a strong acute 
phase immune response, including adhesion and activation of neutrophils  
• In general, glycosylation of Hsa appears to enhance its capacity to interact 


















5.1 Project outline   
Previous studies have demonstrated the ability of S. gordonii to contribute to 
cardiovascular disease IE (Lee et al., 2006; Mosailova et al., 2019). In particular, it 
has been shown that S. gordonii has the capacity to interact with platelets, adhering 
to and subsequently activating them, leading to thrombus formation on heart valves 
(Haworth et al., 2017a; Keane et al., 2013; Petersen et al., 2010). In addition, the 
ability of S. gordonii to adhere to components of the ECM, such as fibronectin and 
vitronectin (Haworth et al., 2017b; Jakubovics et al., 2009), is proposed to enable 
S. gordonii to adhere to damaged cardiac tissue. For both platelet and ECM 
interactions, S. gordonii surface adhesins PadA and Hsa have been implicated 
(Haworth et al., 2017b; Keane et al., 2013; Petersen et al., 2010), making them 
potential therapeutic targets for combatting IE. One aspect of IE pathogenesis that 
has been less well explored, however, is the ability of S. gordonii to survive within 
the blood stream.  
To address this knowledge gap, the overall aim of this project was to investigate the 
interactions of S. gordonii with blood components and their potential implications for 
survival, with a particular focus on the role of adhesins PadA and Hsa. Studies were 
also performed to gain a better understanding of the molecular basis of S. gordonii 
interactions with cardiac endothelium. These aims were to be achieved by global 
analysis of essential genes (TraDIS system) and protein interactions (proteomics), 







5.2 S. gordonii survival in serum  
Studies on the ability of S. gordonii to survive within human serum revealed the 
capacity of S. gordonii to survive over a period of 6 hours under varying conditions. 
In general, over this time period, bacterial numbers were reduced but not eliminated. 
Entry of bacteria into the blood stream would be expected to induce a rapid host 
immune response and indeed, evidence of this came from the IPA analysis, with 
significant activation of the APR indicated, alongside recruitment and activation of 
phagocytic cells such as neutrophils and macrophages. In vitro studies presented 
here also directly demonstrated the capacity for S. gordonii to induce neutrophil 
activation and NET release. As had been the original intention with this project, if 
performing studies with whole human blood rather than serum, the presence of 
phagocytic cells, for example, would be expected to significantly reduce S. gordonii 
numbers over the same time period. Supporting this, a recent study found that with 
a 104 CFU inoculum, only 5% of S. gordonii cells survived after 6 h in whole blood 
(Ha et al., 2020). Nonetheless, bacteria were still not completely cleared, supporting 
the hypothesis that S. gordonii has the capacity to protect itself against such 
defences. Moreover, this project has identified potential mechanisms by which S. 
gordonii may be able to achieve this, including those mediated by PadA and Hsa 
directly, as discussed below. 
 
5.2.1 Interactions with the complement system  
Targeting of bacterial cells by the complement system for subsequent removal by 
opsonophagocytosis is a major aspect of the APR, and the proteomics data 




complement proteins, at least in part mediated by PadA and Hsa. Nonetheless, 
these two adhesins also engaged proteins that may afford protection 
against complement-mediated killing, namely fibrinogen, Factor H and vitronectin. 
This may explain, at least in part, why S. gordonii mutants lacking these proteins 
were impaired in serum survival relative to wild-type.  
By driving the degradation of C3b, recruitment of Factor H can inhibit C3b deposition 
on the bacterial cell surface, thus allowing the bacterial cell to avoid complement-
mediated killing (Roy et al., 2016). Likewise, recruitment of fibrinogen can impair 
immune recognition of deposited C3b. This has been reported to protect a number 
of bacterial species, including S. suis, S. pyogenes and S. pneumoniae (Andre et 
al., 2017; Carlsson et al., 2005; Pian et al., 2015). It is possible, then, that these 
represent common immune evasion mechanisms amongst streptococci. However, 
as fibrinogen and Factor H were identified via the proteomic studies here, it will be 
important to verify these binding capabilities for S. gordonii and the potential immune 
protective effects. As mentioned, one way in which this could be achieved would be 
to monitor levels of fibrinogen or Factor H vs. C3b deposition on the bacterial cell 
surface by FACS following incubation of S. gordonii in blood or serum. This could 
then be correlated with survival, using both wild-type S. gordonii and the collection 
of PadA and Hsa mutant strains. 
Recruitment of vitronectin to the bacterial cell surface has been widely reported to 
contribute to complement evasion by preventing formation of the MAC (Singh et al., 
2010). Nonetheless, this mechanism has also been found to confer protection on 
Gram-positive bacteria such as S. pneumoniae (Voss et al., 2013). In this study, 
direct binding to vitronectin was shown for both PadA and Hsa, correlating with 




the N-terminal region (unpublished data), PadA and Hsa can target the heparin-
binding site within the C-terminus of vitronectin. To further try and verify if recruiting 
vitronectin is protective, survival studies could be performed using vitronectin-
depleted serum. Complement deposition in the presence of vitronectin could also 
be investigated. With the involvement of two domains within vitronectin, it would also 
be of interest to assess if simultaneous engagement of both sites is required for 
effective attachment, and if PadA and Hsa preferentially target one or other of the 
two domains. This could be explored, for example, by examining binding kinetics 
with different vitronectin domains and in the presence of specific blocking peptides. 
 
5.3 S. gordonii in the progression of IE  
5.3.1 Attachment to cardiac tissue  
Viridans group streptococci such as S. gordonii have a particular association with 
native valve IE. As such, pathogenesis is principally linked with vegetation formation 
on natural heart valves that have experienced some form of damage. Bacteria (and 
platelets) within the blood stream are therefore presented with a roughened surface, 
and it is generally proposed that targeting of ECM and other exposed components 
initiates thrombosis. In support of this, potential targets of interest that were 
identified from the pull-down assay data in this study included collagen and vimentin. 
Using ex vivo pig heart valves, S. mutans has been shown to attach via exposed 
collagen fibres (Avilés-Reyes et al., 2017) and so it is possible that a similar 
mechanism is exploited by S. gordonii. Likewise, vimentin has been associated with 
damaged endothelium and a secretory form has been found on the luminal surface 




target for S. gordonii. Binding to vitronectin may also facilitate the ability of S. 
gordonii to form vegetations, as it is expressed in abundance on the endocardial 
surface (Singh et al., 2010). This was not detected in the proteomics analysis using 
HCAEC lysates, but this may reflect the relative abundance of protein in a whole 
cell lysate and/or the fact that only Hsa was used as the bait protein. To further 
develop this work, it would be of interest to confirm binding by S. gordonii, and 
specifically Hsa, to purified versions of these target proteins. Binding assays with 
damaged cardiac endothelial cells could also be performed, and differential 
immunolabelling of target proteins and bacteria used to demonstrate co-localisation 
by microscopy. 
 
5.3.2 Interactions of S. gordonii with neutrophils  
This work has shown that S. gordonii is a potent stimulator of ROS production and 
thus neutrophil activation. Additionally, S. gordonii induced NETosis, during which a 
neutrophil expels both chromatin and histones in an effort to ‘trap’ bacteria, prior to 
ROS release (Rosales et al., 2017). In both instances, PadA and Hsa were 
implicated. These findings correlate with induction of the APR upon entry of S. 
gordonii into the blood stream and would be expected to contribute to bacterial 
clearance. However, particularly as these effects were observed using immobilised 
bacteria, there are also potential implications for vegetation development. It has 
been suggested that activated platelets can promote neutrophil activation and that 
the subsequent production of NETs further contributes to the generation of 
vegetations on the endocardium (Lee et al., 2006a). Since it is already known that 
the combined effects of S. gordonii Hsa and PadA can activate platelets (Haworth 




neutrophils offers the potential to amplify and thus further exacerbate vegetation 
formation. Studies should therefore progress to exploring the interactions of S. 
gordonii wild-type and Hsa/PadA mutants with both platelets and neutrophils 
simultaneously. 
 
5.3.3 Promotion of thrombosis  
As described, vegetation development in IE is caused by the normal process of clot 
formation occurring at an unwanted site i.e. on the heart valves. Two other 
key aspects that were identified in this study that could enable S. gordonii to 
promote this process were triggering of the coagulation cascade and endothelial cell 
activation. Again, both PadA and Hsa were associated with these effects. Activated 
endothelial cells change from an anti-coagulant state into a prothrombotic state and 
promote the recruitment and activation of platelets. This ultimately leads to 
thrombosis and activation of the extrinsic coagulation pathway, which was also 
identified in this analysis (Liesenborghs et al., 2020). By stimulating these pathways, 
it is clear to see how S. gordonii at the site of endocardial damage could encourage 
formation of the infective vegetation. To further corroborate these data, clotting 
assays could be performed, in which whole human blood is flowed over immobilised 
S. gordonii ± endothelial cells in microfluidic channels (Kastrup et al., 2008). It would 
also be of interest to investigate the cytokine response induced in cardiac 
endothelial cells by S. gordonii. Release of proinflammatory cytokines such as IL-6 
and IL-8 contribute to thrombosis and will also influence the host immune response 






5.3.4 Hypothesised outcome of TraDIS 
Unfortunately, because of COVID-19, the mutant library generated in this work using 
the adapted TraDIS protocol could not be sequenced using Illumina. However, if the 
visit to the Waller group had gone ahead, the aforementioned errors that occurred 
when preparing the library could be resurrected and subsequently undergone next 
generation sequencing (NGS).  
 
Samples are prepared following the adapted protocol previously described and input 
DNA content is measured using qPCR. The screening process can then be carried 
out, whereby TraDIS sequencing primers begin sequencing within the transposon 
sequence. These primers provide an 8-10 base pair ‘transposon tag’ at the 
beginning of each read, which allows the user to verify that each read originates 
from a genuine transposon-chromosome junction. Once the first read is completed, 
DNA is denatured, and the transposon-specific sequencing primer can re-anneal for 
further reads (Barquist et al., 2016). Following sequencing, the read-out data can 
then be mapped against the S. gordonii DL1 genome. To determine whether a gene 
is essential or not, the number of insertions per coding region are quantified. This 
must be normalised for gene length, so the number of unique insertion points within 
the coding sequence is divided by the coding sequence length in bases. This value 
gives the insertion index score, which is used as a measure of essentiality (Goodall 
et al., 2018). Usually with TraDIS, the insertion index score frequency is bimodal – 
it is assumed that genes in the left mode with a low number of insertions are either 
essential for survival or are extremely relevant to the fitness of the bacterium. The 
second mode is associated with genes possessing many insertions, often deemed 
as non-essential (Goodall et al., 2018). Based on this, an exponential distribution 




probability of each gene belonging to each mode can be calculated, with the ratio of 
these values termed the log likelihood score. A gene can therefore be classified as 
essential if its log likelihood score was less than log2(12), based on previous 
protocols carried out by Goodall et al., 2018. 
 
Once the essential genes have been mapped for S. gordonii mutants grown in BHY 
broth, this can be compared to mutants grown in blood, to identify whether any 
interrupted genes impacted the ability of S. gordonii to survive, highlighting the 
potential importance of these given genes in blood survival. Statistical analysis for 
TraDIS can be difficult, however, previous studies observed overestimation of 
essential genes as a key problem with this technique (Barquist et al., 2016). Some 
previous studies have employed a Poissonian model to determine essential genes, 
whereby a P value is derived for an insertion-free region (IFR) of a given length 
against the null hypothesis that, by chance, no insertions occurred in that region 
(Goodall et al., 2018). 
 
Based on previous findings both within the laboratory and literature, it can be 
suggested that S. gordonii surface adhesins, such as PadA and Hsa may be 
essential for survival both in growth media and blood. This was highlighted in this 
project, whereby the removal of PadA and Hsa was shown to significantly reduce 
the ability of S. gordonii to survive in human serum, which would give a similar result 
to blood (Haworth et al., 2017, Nobbs et al., 2009). In addition, it can be 
hypothesised that stress-response genes, iron-sequestering genes and genes 
responsible for metabolism may be identified using TraDIS, as these gene types 
were noted in previous studies by Charbonneau et al., 2017 utilising a different 





In summary, further work needs to be carried out to rectify the issues identified 
during sample preparation, prior to sequencing. However, once these steps have 
been carried out, this technique will provide a useful, novel insight into the gene 
essentiality of S. gordonii which will open many doors for further research on this 
microorganism and its role in both bacteraemia and IE. 
 
5.4 Future work  
5.4.1 Role of additional adhesins  
This work demonstrated the potential roles of both PadA and Hsa in promoting S. 
gordonii survival within blood, but additional adhesins were also implicated. For 
example, although the absence of both PadA and Hsa significantly reduced the 
ability of S. gordonii to bind to vitronectin, adhesion was not ablated, suggesting that 
other adhesins may be involved. A similar trend was seen with neutrophil 
interactions and ROS production. Completion of the planned TraDIS studies is one 
way in which other S. gordonii genes of importance in these studies may be 
identified. These genes and their role in S. gordonii blood survival could then be 
verified by generating and testing specific knockout mutants lacking these genes. 
Of the S. gordonii adhesins described to date, another potential protein of interest 
is SndA. This is known to exhibit DNase activity (unpublished data) and its 
homologue in S. sanguinis, SWAN, has been shown to degrade NETs (Morita et al., 
2014). Given the capacity for S. gordonii to induce NETosis and promote neutrophil 




enzymatic activity of SndA can afford some degree of protection against neutrophil-
mediated killing.  
 
5.4.2 Future studies with Hsa and PadA  
In this study, PadA and Hsa have been shown to bind proteins that may promote 
immune evasion by S. gordonii within the blood stream,and drive infective 
vegetation formation via interactions with cardiac endothelium and the induction of 
processes such as NETosis and the coagulation cascade. Furthermore, while for 
some properties, such as for neutrophil activation, there was evidence of functional 
redundancy, for others, such as induction of NETosis and adhesion to vitronectin, 
the data implied co-operative function. The latter has also been observed in previous 
studies by Haworth et al. (2017), where it was demonstrated that Hsa is reliant on 
PadA expression in order to mediate biofilm formation and binding to both vitronectin 
and the salivary pellicle. To explore this co-dependence further, co-localisation 
studies could be carried out to determine whether these two surface proteins 
complex on the bacterial cell surface. This could be achieved by differentially 
tagging PadA and Hsa using fluorophores and subsequently utilising fluorescence 
microscopy to determine cellular location and proximity to one another (Nadrigny et 
al., 2006). Additionally, this study has provided supporting evidence that 
glycosylation might be required for effective functioning of Hsa.  
Given their suggested scope of activity, these studies have further indicated that 
both PadA and Hsa may serve as therapeutic targets for combatting IE. 
Nonetheless, additional information is still required. For example, where specific 




the specific adhesin domain(s) involved so that approaches such as peptide 
mimetics that block these interactions can be developed. Since current treatment 
for IE requires high dose, long-term antibiotics, such alternative strategies would be 
desirable given the ongoing crisis relating to the spread of antimicrobial resistance 
(Cahill et al., 2017).  
 
5.4.3 Study limitations 
Whilst this study has been valuable in advancing understanding of the ability of S. 
gordonii to survive within blood and to promote IE, in vitro assays are not without 
limitations. One major drawback of this work was the absence of conditions 
associated with the physiological environment, such as turbulent or shear blood 
flow. In order to mimic a more physiologically-relevant environment, more complex 
models could be used going forward in which bacteria and cardiac endothelial cells 
are exposed to blood under the control of an iBidi pump, which provides perfusion 
conditions representative of the human body (Jagau et al., 2019). Ultimately, 
validation of these studies using an animal model would be desirable, due to the 
presence of a more physiologically relevant environment, such as the rabbit aortic 
valve endocarditis model. With this model, vegetations can easily be identified and 
removed (Ge et al., 2008), and rabbit vascular physiology and immune responses 
are relatively close to those of a human, making it a good choice in the study of IE 






5.5 Conclusions  
The overall aims of this work were to investigate the mechanisms by which S. 
gordonii can survive within human blood and contribute to IE pathogenesis. The 
abilities of wild-type S. gordonii and mutants lacking adhesins PadA and Hsa to 
interact with blood components and cardiac endothelium were extensively studied 
using in vitro assays, microscopic techniques and proteomics analyses. The initial 
focus of this project to utilise the high-throughput, next generation sequencing-
based TraDIS system to identify genes required for blood survival unfortunately had 
to be abandoned due to several technical difficulties and ultimately the Covid-19 
pandemic. Nonetheless, this instead provided the opportunity to interrogate relevant 
proteomics data. The culmination of this work had led to the identification of immune 
evasion strategies that may be exploited by S. gordonii to promote blood survival, 
to the discovery of potential receptors that may be targeted by S. gordonii to facilitate 
attachment to damaged cardiac endothelium, and to the identification of additional 
mechanisms, alongside platelet activation, that may allow S. gordonii to exacerbate 
the formation of infective vegetations. This information may serve as a platform from 
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